Below is a partial list of the companies that
will be presenting at this year's conference

May 27-28, 2015

  * Important note about presenting companies   View Full Presenting Company Schedule


22nd Century Group Inc.
22nd Century Group Inc. (XXII)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

22nd Century Group is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants through genetic engineering and plant breeding. The Company’s mission is to reduce the harm caused by smoking. 22nd Century owns or exclusively controls 128 issued patents plus an additional 52 pending patent applications in 96 countries. The Company’s strong IP position led to a licensing agreement with British American Tobacco (“BAT”), the world’s second largest tobacco company.

Acme United Corporation
Acme United Corporation (ACU)   Presenting on Day 2
Industry Sector: Retail and Consumer Products

Acme United Corporation is a leading worldwide supplier of innovative cutting, measuring and safety products to the school, home, office, hardware and industrial markets. Its leading brands include Westcott®, Clauss®, Camillus®, PhysiciansCare® and Pac Kit®. The Company has had five years of increasing sales and earnings, and has been recognized by Forbes, Business Week , and Fortune as among the fastest growing small companies in the U.S.

Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. (ATNM)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Actinium Pharmaceuticals, Inc. is a public biopharmaceutical company specialized in the development of cancer drugs. The Company’s product candidates are based on its patented technology co-developed with Memorial Sloan Kettering Cancer Center (MSKCC) for combining the cancer targeting precision of monoclonal antibodies (mAb) for targeting specific types of cells with the power of alpha emitting radioisotopes, the most potent cancer killing agents in existence. ATNM’s first drug for the treatment of acute myeloid leukemia (AML) has been administered to 49 patients with promising results and the second generation drug candidate is currently in clinical trials with 28 patients treated to date. In addition to leukemia drugs, ATNM’s technology has been used to produce drug candidates for treatment of metastatic colorectal and prostate cancers, antiangiogenesis (prevention of blood supply to and growth of many solid cancers) and bone marrow ablation, part of a curative treatment for leukemias, lymphomas and multiple myeloma.

ADMA Biologics
ADMA Biologics (ADMA)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

ADMA is a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases. ADMA's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-compromised for medical reasons.

ADMA's lead product candidate, RI-002 is a specialty plasma-derived, polyclonal, Intravenous Immune Globulin, or IGIV, derived from human plasma containing naturally occurring polyclonal antibodies (e.g., Streptococcus pneumoniae, H. influenza type B, Cytomegalovirus (CMV), measles, tetanus, etc.) as well as standardized, high levels of antibodies to respiratory syncytial virus (RSV). ADMA is pursuing an indication for the use of this specialty IGIV product for treatment of patients diagnosed with primary immune deficiency diseases, or PIDD. Polyclonal antibodies are proteins that are used by the body's immune system to neutralize microbes, such as bacteria and viruses. Data review indicates that the polyclonal antibodies that are present in RI-002 support the ability of this product to prevent infections in immune-compromised patients. ADMA's analysis of the data from its pivotal Phase III trial demonstrated that RI-002 met the primary endpoint with zero serious bacterial infections (SBI) reported.

Aemetis, Inc.
Aemetis, Inc. (AMTX)   Presenting on Day 2
Industry Sector: Energy and Natural Resources

Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in the California Central Valley near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals.

Amarantus Bioscience Holdings, Inc.
Amarantus Bioscience Holdings, Inc. (AMBS)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Amarantus BioScience Holdings, Inc. (“Amarantus”) is a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis (programmed cell death).

Anavex Life Sciences Corp.
Anavex Life Sciences Corp. (AVXL)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Anavex Life Sciences Corp. is a publicly traded biopharmaceutical company dedicated to the development of novel drug candidates to treat central nervous system (CNS) diseases, pain and various types of cancer. The Company’s lead drug candidates, ANAVEX 2-73 and ANAVEX PLUS, the combination of ANAVEX 2-73 and donepezil (Aricept®), are currently being evaluated in a Phase 2a clinical trial for Alzheimer’s disease. ANAVEX 2-73 is an orally available drug candidate that targets sigma-1 and muscarinic receptors and has successfully completed a Phase 1 study with a clean data profile. Preclinical studies demonstrate its potential to halt and/or reverse the course of Alzheimer’s disease. The drug combination, ANAVEX PLUS, produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually. Recent positive preclinical data indicates that ANAVEX 2-73 also exhibits anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties, indicating its potential to treat additional CNS disorders, including epilepsy and others.

Angionetics, Inc.
Angionetics, Inc. (Private)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Angionetics is a privately held operating unit of Taxus Cardium Pharmaceuticals Group (Trading Symbol: CRXM). Angionetics is focused exclusively on the development and commercialization of novel DNA-based therapeutics designed to promote the heart’s innate natural capacity to modulate the formation and growth of microvascular circulation to enhance blood flow (perfusion) in patients with a variety of ischemia-driven disease conditions and persistent angina pectoris due to cardiac microvascular insufficiency (CMI), and other cardiovascular disease conditions.

Angionetics’ lead Phase 3 product candidate, Generx® alferminogene tadenovec [Ad5FGF-4], is a first in class, single-dose, disease altering therapeutic specifically targeted to the cardiac micro-vasculature, and designed to endogenously initiate the formation of new biologic structures, to increase the level of micro-vascularity, enhance cardiac perfusion, and improve cardiac performance, as measured by exercise tolerance and the occurrence and severity of myocardial ischemia-driven angina. Angionetics’ product candidates are designed to easily fit within the current practice of medicine, as single-dose treatments, which are administered by interventional cardiologists using standard cardiac catheters, during an approximately one-hour, out-patient, angiogram-like procedure which is conducted in a hospital or medical center.

Angionetics recently announced an international Generx strategic co-development agreement with Dr. Reddy’s Laboratories Ltd. (NYSE: RDY). Angionetics also recently announced an initial equity investment of $3.0 Million for a 15% equity interest to advance the Generx clinical development program.

Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (APDN)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Using biotechnology as a forensic foundation, we provide botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Whether working in supply chain security, brand protection or law enforcement applications, it is our goal to help establish secure flourishing environments that foster quality, integrity and success. With secure taggants, high-resolution DNA authentication, and comprehensive reporting, our botanical DNA-based technologies are designed to deliver what we believe to be the greatest levels of security, deterrence and legal recourse strength.

AstroTech Corporation
AstroTech Corporation (ASTC)   Presenting on Day 2
Industry Sector: Industrials

Astrotech Corporation is an Austin, TX based technology company that has evolved from over 30 years in the human spaceflight, Space Shuttle, and Department of Defense satellite programs. The company has become a leader in the commercialization of government sponsored advanced space technologies.

1st Detect Corporation has developed a mass spectrometer that was designed for use on the International Space Station, but also revolutionizes the chemical detection and analysis market by delivering laboratory performance mass spectrometry in a small, affordable, and portable package. 1st Detect's technology is useful in the semiconductor, food & beverage processing, laboratory, process control, explosive detection, and chemical warfare markets.

Astrogenetix Corporation is the result of over $4 Billion spent by NASA over a 25 year period on experiments conducted in sustained microgravity, where results were only achieved while orbiting in space. Astrotech designed and flew 1,113 of these experiments and after an extensive review, discovered that microgravity greatly enhanced the discovery of valuable vaccine and therapeutics. The company has completed 12 successful biomarker discovery missions to the International Space Station and has identified a salmonella vaccine candidate, while 10 additional discoveries are in the pipeline. NASA has awarded Astrogenetix 26 free flights to the $130 Billion ISS National Laboratory, along with full crew support.

Astral Images, Inc. was created to commercialize identified government funded satellite image correction technologies. Along with the acquisition of certain established defect correction technologies, first funded by IBM and Kodak, Astral is positioned to be the world leader in the technology required to convert and repair feature films and film based television series to the new digital HDR Ultra-High Definition 4K standards.

Avant Diagnostics
Avant Diagnostics (AVDX)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Avant Diagnostics, Inc. is a medical diagnostic technology company that specializes in first large panel biomarker screening.  Our first test, OvaDx® detects for pre-symptomatic ovarian cancer.   OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Pre-clinical research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma.  Upon FDA 510K approval, Avant Diagnostics intends to sell or license OvaDx® as a diagnostic test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer.

B Communications LTD
B Communications LTD (BCOM)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

B Communications is a telecommunications-oriented holding company and its primary holding is its controlling interest in Bezeq, The Israel Telecommunication Corp., Israel’s largest telecommunications provider (TASE: BEZQ).

BioCurity Holdings, Inc.
BioCurity Holdings, Inc. Private
Industry Sector: Healthcare and Life Sciences

BioCurity Holdings, Inc. holds fundamental intellectual property for addressing a serious unmet need: preservation of healthy tissue that is bombarded with radiation in the treatment of cancer through radiation therapy.This is a large, addressable market involving 6.35 million patients annually, including 500,000 in the United States alone ($3 billion market), with the typical treatment involving about 20 radiation sessions. Collateral damage from traditional therapies includes burning skin, loss of salivary flow, fluid in the lungs, inflammation and ulcers. These adverse side effects result in reduction of radiation dosages below optimal treatment levels to reduce adverse side effects from the therapy.

BioCurity’s technology utilizes cerium oxide nanoparticles to scavenge the free radicals that are produced through radiation therapy (which damage the healthy tissue), while leaving the radiation treatment intact for the treatment of cancer cells. The Company has a strong Intellectual Property platform, including numerous granted patents and pending patents. The IP has shown stability and effectiveness in prevention and treatment of adverse side effects in pre-clinical studies, without a showing of toxicity. The Company is seeking additional capital or support to fund and run clinical studies as a prelude to moving its technology through the approval process, either independently or in tandem with a strategic partner. The Company and the 2 founders of BioCurity are open to adding individuals as part of management who directly enhance the depth or bandwidth of the current management team.

BioLife Solutions
BioLife Solutions (BLFS)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

BioLife Solutions develops, manufactures and markets biopreservation media and high performance thermal packaging products for cells, tissues, and organs. The Company’s proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife’s products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife’s enabling technology provides academic and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs.

BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (BRTX)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

BioRestorative Therapies, Inc. develops products and medical therapies using cell and tissue protocols, primarily involving adult stem cells, including:
  • Disc/Spine Program: Our lead cell therapy candidate, brtxDISC (DiscImplantedStem Cells), is a product formulated from autologous (or person’s own) cultured mesenchymal stem cells (“MSCs”) collected from the patient’s bone marrow. We intend that the product will be used for the non-surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. The treatmentinvolves collecting a patient’s own stem cells, culturing and cryopreserving the cells, and then having a physician inject brtxDISC into the patient’s damaged disc in an outpatient procedure. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and potentially face the prospect of surgery.
  • ThermoStem® Program: We are developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (“BAT”). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.

BioSculpture Technology, Inc.
BioSculpture Technology, Inc. (Private)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

BioSculpture Technology, Inc. ("BST") is a commercial stage medical device manufacturer developing a patented and prototyped minimally invasive device for the endoscopic removal of visceral or “belly” fat as a new treatment of obesity, metabolic syndrome and type 2 diabetes mellitus. We believe our method and device will save lives, improve life outcomes, and significantly reduce healthcare costs.

BioSig Technologies, Inc.
BioSig Technologies, Inc. (BSGM)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

BioSig Technologies, Inc. is a medical device company that has developed a proprietary technology platform designed to greatly improve the rapidly growing $3 billion electrophysiology (EP) marketplace. Led by a proven management team and a veteran, independent Board of Directors, Los Angeles-based BioSig is preparing to commercialize its PURE EP™ System.

PURE EP is designed to improve outcomes of EP studies and cardiac catheter ablation, shorten ablation procedure times and reduce recurrence rates. It is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making clinical decisions in real-time. PURE EP acquires and displays high-fidelity cardiac signal recordings and provides guidance in identifying ablation targets - areas of tissue to destroy that otherwise create a heart rhythm disturbance; this information is not easily obtained, if at all, from any other EP equipment on the market today.

BioSig will seek FDA 510(k) approval for its PURE EP System.  The Company has already achieved proof of concept validation at UCLA’s EP & Animal Labs. BioSig is collaborating with several of the nation’s most prestigious cardiac arrhythmia centers to develop, refine and, ultimately, commercialize the PURE EP System, including Texas Cardiac Arrhythmia Institute, UCLA Cardiac Arrhythmia Center, U.H. Case Medical Center in Cleveland, William Beaumont Hospital in Michigan, Mount Sinai Medical Center in NY, and Mayo Clinic in Minnesota.

Presenting Company Sponsor

Blue Calypso, Inc.
Blue Calypso, Inc. (BCYP)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Blue Calypso, Inc. develops and delivers mobile engagement and social advocacy solutions for retailers and product manufacturers using its patented portfolio of products including Mobile ADvantage™, KIOSentrix™, DashTAGG® and SocialECHO™. The Company employs its unique platform to connect consumers to brands, drive store traffic, increase shopper spend and shorten the path-to-purchase. The Blue Calypso platform includes extensive big data analytics, tracking consumer engagement such as the spread of shared content, attribution, geo-location and offer redemption. Brands on this platform have key insight into the performance of their content and the sentiment of their customers in real-time. 

Calpian/Money on Mobile
Calpian/Money on Mobile (CLPI)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Calpian, Inc. is a payment processor with operations in the US and India. The Company's subsidiary, Money on Mobile is India's largest cell phone payments network serving over 7 million people each month with bill payment services, prepaid cell phone sales, prepaid television time, and other similar payment services. The company's services are growing over 20% per month on average in 2015.

Capnia, Inc.
Capnia, Inc. (CAPN)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Capnia, Inc. develops and commercializes novel products based on its proprietary technologies for precision metering of gas flow. Capnia's lead product CoSense® is based on the Sensalyze™ Technology Platform. It is a portable, non-invasive device that rapidly and accurately measures carbon monoxide (CO) in exhaled breath. CoSense has 510(k) clearance for sale in the U.S. and has received CE Mark certification for sale in the European Union. CoSense is used for the monitoring of CO from internal sources (such as hemolysis, a dangerous condition in which red blood cells degrade rapidly), as well as external sources (such as CO poisoning and smoke inhalation). The initial target market is newborns with jaundice that are at risk for hemolysis, comprising approximately three million births in the U.S. and European Union. Capnia's proprietary therapeutic technology uses nasal, non-inhaled CO2 and is being evaluated to treat the symptoms of allergies, as well as the trigeminally mediated pain conditions such as cluster headache, trigeminal neuralgia and migraine.

Car Charging Group, Inc.
Car Charging Group, Inc. (CCGI)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Car Charging Group, Inc. is a pioneer in nationwide public electric vehicle (EV) charging services, enabling EV drivers to easily recharge at locations throughout the United States. Headquartered in Miami Beach, FL with offices in San Jose, CA; New York, NY; and Phoenix, AZ; CarCharging's business model is designed to accelerate the adoption of public EV charging.

Through its subsidiary, Blink Network, CarCharging also provides residential EV charging solutions for single-family homes. For more information, please visit

CarCharging has strategic partnerships across multiple business sectors including multi-family residential and commercial properties, parking garages, shopping malls, retail parking, and municipalities.

Cell Source, Inc.
Cell Source, Inc. (CLCS)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company’s patented "Veto-Cell" technology represents a major breakthrough in immune system management - safe and selective “tolerizing” of immune response.

Cell Source’s technology addresses one of the most fundamental challenges in human immunology: how to tune immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats.

Cell Source is currently commercializing this groundbreaking innovation. Potential applications range from facilitating bone marrow and organ transplantation to effectively treating both blood cancers (e.g., Lymphoma) and non-malignant congenital diseases (e.g., Sickle Cell Anemia).

Pending clinical trials aspire to show dramatic improvements in the treatment of lymphoma and leukemia.

Cella Energy
Cella Energy (Private)   Presenting on Day 2
Industry Sector: Energy and Natural Resources

Cella Energy is an advanced materials and products company that delivers high performance hydrogen based power in aerospace, UAV, automotive and portable energy applications in military and commercial markets. This disruptive technology is based on its proprietary formulation for solid hydrogen storage which is safe, economical and outperforms lithium ion batteries by 3X, and has advantages over compressed hydrogen. Current products being developed with major partners include aircraft electrical power systems to replace carbon based fuels, electric UAV�s with 3X the flight duration of lithium ion batteries, electric vehicle range extenders and light weight battery replacement systems for the military, with future development aimed at extending these applications to consumer markets. Cella Energy is privately owned, headquartered at the Rutherford Appleton Labs in the UK, where the technology was developed, and at the Kennedy Space Center in the US. Cella Energy is no longer pre-revenue, and expects to undertake a further equity raise in 2015 to accelerate developing its technology and products.

Cel-Sci Corp
Cel-Sci Corp (CVM)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. Its lead investigational therapy is Multikine (Leukocyte Interleukin, Injection), currently being studied in a pivotal global Phase III clinical trial. Multikine is the first immunotherapeutic agent being developed as a potential first-line treatment for advanced primary head and neck cancer. CEL-SCI is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients and as a vaccine (CEL-2000) for Rheumatoid Arthritis (currently in preclinical testing) using its LEAPS technology platform. The investigational immunotherapy LEAPS-H1N1-DC treatment involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1), and the Spanish Flu, as CEL-SCI scientists are very concerned about the possible emergence of a new more virulent hybrid virus through the combination of H1N1 and Avian Flu, or maybe Spanish Flu. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.

Cemtrex Inc.
Cemtrex Inc. (CTEI)   Presenting on Day 2
Industry Sector: Industrials

Cemtrex, Inc. is a diversified global engineering and manufacturing company that provides a wide array of solutions to meet today's technology challenges. Cemtrex, through its wholly owned subsidiaries, provides electronic manufacturing services of custom engineered high end industrial & medical grade printed circuit board assemblies, emission monitors & instruments for industrial processes, and environmental control & air filtration systems for industries & utilities.

CES Synergies, Inc.
CES Synergies, Inc. (CESX)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

CES Synergies, Inc., through its subsidiary, Cross Environmental Services, Inc., is a specialty environmental services company providing quality environmental contracting solutions, demolition and remediation services to commercial and industrial customers, as well as federal, state and municipal entities.

Cesca Therapeutics
Cesca Therapeutics (KOOL)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Cesca Therapeutics Inc. ( is engaged in the research, development and commercialization of autologous cell - based therapeutics for use in regenerative medicine. The Company is a leader in the develop ment and manufactur e of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. These include:
  • SurgWerks ™ ; proprietary stem cell therapy point - of - care kit s for the treatment of vascular and orthopedic indications that integrate the following indication specific elements :
    • Cell harvesting
    • Cell processing and selection
    • Cell diagnostics
    • Cell delivery
  • CellWerks TM ; a proprietary stem cell laboratory kit for the p rocessing of target cells used in the treatment of oncological and hematological disorders.
  • The AutoXpress ® (AXP) ; a proprietary automated device , along with companion sterile blood processing disposables , for the harvesting of stem cells from cord blood.
  • The MarrowXpress ® (MXP) ; a derivative product of the AXP and its accompanying disposable bag set, for the isolat ion and concentrat ion of stem cells from bone marrow. Self - powered and microprocessor - controlled, the MXP contains flow control optical sensors that volume - reduces blood (RBC’s and plasma) from bone marrow (stem cells) to a user defined volume in 30 minutes while retaining over 90% of mononuclear cells ( MNCs ) .
  • The Res - Q™ 60 (Res - Q) ; a point - of - care system designed for the preparation of cell conc entrates, including stem cells, from bone marrow aspirates and whole blood for platelet rich plasma (PRP).
  • The BioArchive ® System ; an automated cryogenic device, used by cord blood stem cell banks in more than 30 countries , for cryopreserv ation and archivi ng of cord blood stem cell units for transplant.

Chanticleer Holdings, Inc.
Chanticleer Holdings, Inc. (HOTR)   Presenting on Day 2
Industry Sector: Retail and Consumer Products

Headquartered in Charlotte, NC, Chanticleer Holdings together with its subsidiaries, owns and operates restaurant brands in the United States and internationally. The Company is a franchisee owner of Hooters® restaurants in international markets including Australia, South Africa, and Europe, and two Hooters restaurants in the United States. The Company also owns and operates American Burger Co., BGR: The Burger Joint, and owns a majority interest in Just Fresh restaurants in the U.S.

Chanticleer’s growth strategy is to expand these brands in U.S. and emerging markets through accretive acquisition, franchising, and organic growth. To date, the Company has forty-seven company-owned and franchise locations worldwide including fourteen Hooters restaurants, six American Burger Co. restaurants, seven Just Fresh locations and twenty BGR locations.

Check Cap Ltd
Check Cap Ltd (CHEK)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Check-Cap is a clinical stage medical diagnostics company developing an ingestible imaging capsule for the detection of colorectal cancer and clinically-significant pre-cancerous polyps. Unlike other colon screening methods, Check-Cap’s imaging capsule can be used without prior fasting or cleansing of the colon. This provides a significant advantage over current procedures—such as optical colonoscopy, computer tomographic colonography (CTC) and other capsule-based products—which are either invasive, require the patient to fast for several hours, or involve other uncomfortable bowel preparation.

Colorectal cancer is the second leading cause of death from cancer in the United States, but roughly one-half of Americans over the age of 50 do not undergo colon cancer screening due in large part to the pain, discomfort and embarrassment related to current screening methods. Check-Cap believes that its preparation-free alternative will increase compliance with current screening recommendations.

The Check-Cap imaging capsule utilizes low-dose x-rays to generate high-resolution, three-dimensional images of the colon while traveling naturally through the patient’s gastrointestinal tract while the patient continues his or her normal daily routine. The use of x-ray technology allows the capsule to image the lining of the colon even when surrounded by intestinal content, meaning the patient can eat normally during the procedure. The data collected by the capsule is transmitted to an external data recorder worn by the patient, providing a system that is convenient for both patients and physicians.

In late 2015, Check-Cap plans to file for a CE mark for the marketing and sale of the Company’s endoscopy capsule in the European Union and expects to perform post-marketing studies in Europe following CE marking to collect additional clinical data to support market adoption. Check-Cap anticipates initiating a clinical study during 2016 in the US for FDA clearance.

China Information Technology, Inc.
China Information Technology, Inc. (CNIT)   Presenting on Day 2
Industry Sector: Software and Business Services

China Information Technology, Inc. is a leading Internet service company that provides cloud-based platform, exchange, and big data solutions enabling innovation and smart living in the education, health care, new media, finance and transportation sectors in China.

Leveraging its proprietary Cloud-App-Terminal model, CNIT has disrupted the traditional media industry with its innovative "Cloud Nest" big data services. CNIT provides fully integrated smart data platforms to governments, enterprises and urban users. CNIT has also created a robust Internet ecosystem that enables vertical industry applications with cloud media, cloud meeting, Taoping Net, Tao Meeting, Touch One Pass, Healthcare One Pass, Shopping One Pass.

In 2004, Mr. Jianghuai Lin founded CNIT with his team. In 2008, the Company went public on the NASDAQ Stock Market. In 2009, CNIT was selected as one of the “Deloitte Asia Pacific Technology Fast 500”. In 2010, the Company was selected by Forbes as one of “China’s Potential Enterprises 20”. In 2011, the Company was selected as one of the “Forbes China Best Small and Medium Enterprises”. In 2013, CNIT was added to the NASDAQ Golden Dragon China Index. In 2014, the Company launched China’s first integrated cloud platform for industry applications.

Upholding its core values of  “Responsibility and Professionalism” , CNIT will continue to innovate, collaborate, and lead the transformation of the new media industry landscape and create value the society through its proprietary, cutting-edge Cloud-App-Terminal model platform.

ChromaDex Corporation
ChromaDex Corporation (CDXC)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

ChromaDex® is an innovative natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its unique business model which utilizes its wholly-owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as “phytochemicals”), chemistry and analytical testing services and product regulatory and safety consulting (as Spherix Consulting). The Company provides seamless science-based solutions to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries. 

CounterPath Corporation
CounterPath Corporation (CPAH)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

CounterPath Corporation, is an award-winning provider of SIP-based desktop and mobile VoIP software products and solutions. An industry and user favorite, CounterPath’s Bria softphones for desktop and mobile devices, together with the Company’s server applications and Fixed Mobile Convergence (FMC) solutions, enable service providers, OEMs and enterprises large and small around the globe to offer a seamless and unified communications experience across both fixed and mobile networks. Standards-based, cost-effective and reliable, CounterPath’s award-winning solutions power the voice and video calling, messaging, and presence offerings of customers such as Alcatel-Lucent, AT&T, Avaya, BroadSoft, BT, Cisco Systems, GENBAND, Metaswitch Networks, Mitel, NEC, Network Norway, Rogers and Verizon.

CryoPort, Inc.
CryoPort, Inc. (CYRX)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Cryoport provides end-to-end cryogenic logistics solutions to the life sciences industry through the combination of purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. Its competencies range from skilled, total turnkey management of the entire life sciences cold chain logistics process to complex total management solutions for outsourced cold chain logistics. Its packaging, built around its Cryoport Express® liquid nitrogen dry vapor shippers, is validated to maintain a constant -150°C temperature for a 10-plus day dynamic shipment duration. Its information technology boast a Cryoportal™ Logistics Management Platform which manages the entire shipment process, including initial order input, document preparation, customs clearance, integrator/courier management, shipment tracking, issue resolution, and delivery. Cryoport uses recyclable and reusable components providing an environmentally friendly solution. Cryoport solutions can record the "chain of condition" and "chain of custody" for shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes.

Cupcake Digital, Inc.
Cupcake Digital, Inc. (Private)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Founded in 2012, Cupcake Digital, Inc. gives kids the opportunity to interact with the characters they love by transforming children’s entertainment properties into award-winning apps. The Company’s apps are consistently top-ranked on the Apple App Store, Amazon Appstore for Android, Google Play and the Barnes & Noble NOOK Store. Cupcake’s licensed IP portfolio includes Wow! Wow! Wubbzy!, Jim Henson’s Fraggle Rock, Strawberry Shortcake, VeggieTales, Yo Gabba Gabba!, Animal Planet, The Smurfs, Sid the Science Kid, Barney, Mike the Knight, Cloudy with a Chance of Meatballs, Puss In Boots, How To Train Your Dragon, Madagascar, Shrek, and Kung Fu Panda.

Presenting Company Sponsor

DARA Biosciences Inc.
DARA Biosciences Inc. (DARA)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

DARA is a specialty pharmaceutical company dedicated to the commercialization of oncology treatment and oncology supportive care products. DARA is poised for significant growth and is focused on:
  • Synergistic Commercial Products: Three commercial products (Gelclair®, Oravig®,and Soltamox®) are FDA approved, cleared and licensed for sale in the US. Our products have the potential for use in the same patient resulting in significant sales and marketing efficiencies.
  • Product Development: KRN5500 is a Phase 2 Fast-Track drug in development for treatment of painful chronic chemotherapy induced peripheral neuropathy(CCIPN) that provides significant upside potential for an unmet medical need and also fits our commercial focus. KRN5500 is a Phase 2 product candidate which was awarded Fast-Track status and has received FDA Orphan Drug Designations for CCIPN and multiple myeloma.

DataTrak International Inc.
DataTrak International Inc. (DTRK)   Presenting on Day 1
Industry Sector: Technology - Media and Internet

DATATRAK is an industry-leading provider of eClinical solutions and services. The DATATRAK ONE® Unified Experience™ platformremove complexities in clinical research, delivering improved data quality, greater patient safety, and time and cost savings. Our Unified eClinical® platform powers all DATATRAK solutions, delivering efficiencies of a single data source, reducing risk. With industry-leading system reliability built for the Cloud, an exceptional User Experience, and a greater value, DATATRAK ONE® Unified Experience™ leads to better site compliance, better data, and ultimately a safer trial.

Diagnostic Lab Corporation
Diagnostic Lab Corporation (Private)   Presenting on Day 1
Industry Sector: Technology - Media and Internet

Diagnostic Lab Corporation (DLC) is a biotechnology company dedicated to science, safety, and standards in the emerging cannabis sector. DLC is poised to be the market leader in truth-in-labeling, brand identification, and certification in cannabis. DLC has developed cutting edge testing devices and kits, certifications, safe handling protocols, and a revolutionary online patient platform. Currently, there is an overwhelming demand for such solutions. Unlike most emerging companies in the sector, DLC is committed to utilizing science and medicine. Our advisory board of medical doctors and scientists are first in class and are experts within their discipline. DLC’s chairman is Stephen L. Brenner, MD an orthopedic surgeon and wellness physician.

Direct Insite Corp
Direct Insite Corp (DIRI)   Presenting on Day 1
Industry Sector: Software and Business Services

Direct Insite™ provides a powerful platform for unified working capital management that facilitates over $160 billion worth of transactions annually between more than 375,000 companies worldwide.  Direct Insite’s clients include IBM, Siemens, BE Aerospace, Saint Gobain, Carlson, and one of the largest financial institutions in the world.  The flagship component of Direct Insite’s unified working capital management platform is PAYBOX™, an innovative receivables automation solution that combines electronic invoicing, online approvals and adjustments, electronic payments, and integration with any legacy accounting, ERP or lockbox system.  PAYBOX™ is primarily sold through banks to corporate users of their treasury management and lockbox services.  Banks and corporations use PAYBOX™ to reduce Days Sales Outstanding, lower costs, and improve straight-through AR posting.

Dot Hill Systems Corp.
Dot Hill Systems Corp. (HILL)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Dot Hill Systems Corp. designs, manufactures and markets a range of software and hardware storage systems for the entry-level and midrange storage markets. We focus on selling through server-based original equipment manufacturers (OEMs), such as Hewlett-Packard, Dell Inc., Lenovo, Advanced Micro Devices, Inc., and Stratus Technologies; as well as into vertical markets, which primarily include media and entertainment, telecommunications, HPC, Digital Image Archive, Big Data Analytics and oil and gas. Our vertical market customers are OEMs who embed our products into their solutions, as well as resellers.

Echo Therapeutics, Inc.
Echo Therapeutics, Inc. (ECTE)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Echo Therapeutics, Inc. is developing its non-invasive, wireless continuous glucose monitoring (CGM) system with potential use in the wearable-health consumer market and the diabetes outpatient market. A significant longer-term opportunity may also exist in the hospital setting. Echo has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications.

Energous Corporation
Energous Corporation (WATT)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Energous Corporation is developing WattUp, a wire-free charging technology that will transform the way people charge and power their electronic devices at home, in the office, in the car and beyond. WattUp is a revolutionary, patent- and trademark-pending solution that delivers intelligent, scalable power via the same radio bands as a Wi-Fi router. WattUp differs from current wireless charging systems in that it will deliver meaningful, useable power, at a distance, to multiple devices, resulting in a wire-free experience that saves users from having to remember to plug in their devices or place them on a mat.

Engagement Labs
Engagement Labs (CVE: EL)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Engagement Labs offers intelligent social data, analytics and insights for organizations that are actively engaging on social networks. Offered as a SaaS or through an API, the eValue™ analytics platform allows brands to measure and maximize the effectiveness of their social media marketing campaigns, as well as measure that of their competitors across major social networks Facebook, Twitter and YouTube. Engagement Labs maintains offices in Montreal, Toronto and Paris.

Finjan Holdings, Inc.
Finjan Holdings, Inc. (FNJN)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Finjan, founded in 1997, is a technology company committed to investing in and enabling technology innovation. Our early technology innovations and products helped define the state-of-the-art for detecting and deflecting software intrusions and malicious code delivery, over internet and private networks, to devices located at endpoint connections. Beginning with the formation of the company, we have invested considerable time, effort and resources to secure our inventions with US and Foreign patents. As Finjan’s patented technologies have become increasingly relevant across today’s growing security sector, we continue to seek licenses to our patents across the industry. Finjan has successfully licensed its patents to a number of industry players, demonstrated a strong commitment to pursuing unlicensed companies through litigation, resulting in more than $145 million in licensing revenues, to date. The company continues to invest in the security sector and intends to broaden its technology and intellectual property holdings through continued acquisition, investment, and strategic partnerships.

Furlocity (Private)   Presenting on Day 1
Industry Sector: Technology - Media and Internet

Furlocity is a company founded on the vision of making pet parents’ lives easier by using 21st century technology to access the services pet parents need for their four legged family members. is the result of that vision, as it is the premier pet accommodations website, providing an online technology platform that enables pet owners to search, identify and book trusted pet boarding stays, veterinary services and pet-friendly hotels. Furlocity’s innovative technology simplifies the booking process for pet owners, and ultimately enhances the overall experience for their beloved pets. Furlocity’s online marketplace currently includes top-rated pet boarding facilities and veterinarians in over 105 cities and 30 states, and more than 100,000 pet-friendly hotels across the United States.

Furlocity was founded in San Diego in 2012 by busy ‘pet parents’ who understood the need to establish a more intuitive process for finding safe pet accommodations options. Furlocity was launched to help foster mutually beneficial relationships between pet owners and trusted pet care services providers.

Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd. (GLMD)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Galmed is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel, once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates, or FABACs. Galmed believes that its product candidate, aramchol, has the potential to be a disease modifying treatment for fatty liver disorders, including NASH, which is a chronic disease that Galmed believes constitutes a large unmet medical need.

Game Sports Network
Game Sports Network Private   Presenting on Day 2
Industry Sector: Technology - Media and Internet

GSN’s is a platform company offering skill based mobile first daily fantasy sports applications. Our in market products HotRoster and Maxim Fantasy simplify DFS play. As both B2C and B2B offerings, GSN’s patent pending games offer media companies and legacy regulated companies products that can drive cross sales and higher customer NPV. By redesigning daily fantasy sports prizes and events on a year round basis, GSN has created a disruptive, consumer-first experience with an immersive app that allows players to tailor their game play to their own skill level.

General Employment Enterprises, Inc.
General Employment Enterprises, Inc. (JOB)   Presenting on Day 2
Industry Sector: Software and Business Services

General Employment Enterprises, Inc. (the "Company") was incorporated in the State of Illinois in 1962 and is the successor to employment offices doing business since 1893. The Company provides staffing services through a network of offices located in the United States. The Company operates in two industry segments, providing professional staffing services and solutions and light industrial staffing services through the names of General Employment, Ashley Ellis, Triad and Omni-One. Also, the Company serves the healthcare market through its Scribe Solutions brand by staffing medical scribes to assist medical practices and hospitals with electronic medical record (EMR) management.

GeoVax Labs, Inc.
GeoVax Labs, Inc. (GOVX)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

GeoVax Labs, Inc. is a clinical-stage vaccine development company. Our lead programs are focused on Ebola virus and HIV. Our vaccine delivery technology generates virus-like particles (VLPs) that are effective at eliciting safe and effective immune responses. All of the clinical trials for our preventive HIV vaccine have been conducted by the HIV Vaccine Trials Network with funding from the NIH. Our proprietary Ebola vaccine technology has been developed internally and our HIV vaccine technology was developed in collaboration with Emory University, the NIH, and the CDC.

Green Jane Inc.
Green Jane Inc. (Private)   Presenting on Day 2
Industry Sector: Software and Business Services

Green Jane Inc. is a Colorado-based cannabis company that licenses, brands and provides business services to the marijuana industry. The company is comprised of three divisions: Green Jane Services, which helps cultivators maximize production and retailers maximize revenues and margins; Green Mountain Assets, which develops and leases cannabis-capable properties; and Growth Innovations, an in-house venture group that incubates and monetizes products, services and technology that supports Green Jane's business strategy.

Greenwood Hall, Inc.
Greenwood Hall, Inc. (ELRN)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Greenwood Hall provides colleges and universities with solutions that enable them to adapt and grow in a rapidly changing higher education marketplace. Our cloud-based platform provides schools with the comprehensive operating infrastructure they need to recruit, enroll, engage, support, and create enduring relationships with students. By combining strategies, technology, and people resources, Greenwood Hall is able to provide an unparalleled student experience that maximizes student outcomes while setting a new standard for the future of higher education.

Grom Social
Grom Social (Private)   Presenting on Day 1
Industry Sector: Technology - Media and Internet

After being kicked off of Facebook twice by his parents, Zach Marks envisioned creating a great social media alternative for kids. So, Zach, along with his brothers, sister, and friends of the family, developed the platform and brought the various characters to life. The beta platform of Grom Social was officially launched in November of 2012 as "A Social Network By Kids For Kids™"

Grom Social has many cool features for kids:
  • Connect with friends
  • Chat and join in group discussions
  • Share photos
  • Post status updates and interesting stories
  • Make their own avatar (“Gromatar”) for their profile photo
  • Watch funny videos
  • Play games and more
Zach’s ingenuity, Grom Social’s value proposition, and the Marks family’s generous and active lifestyle, have attracted kids from around the world, as well as industry leaders, to the site.

Grom Social’s Value Proposition
A Safe, Educational, Fun, and Highly Interactive social media experience for kids, ages 5 - 16 Promoting Social Responsibility amongst Members including No Bullying, Saying No to Drugs, and Saying No to Smoking, Promoting Mutual Respect, a Sense of Community, and Giving Back to Others. A Kid-Friendly Environment with 24/7 live-monitoring and Direct Parental Oversight that Mitigates the Risks Found on Other Social Networking Sites.

GWG Holdings, Inc.
GWG Holdings, Inc. (GWGH)   Presenting on Day 2
Industry Sector: Financial Services & Asset Management

GWG Holdings, Inc. is a specialty finance company and leader in the life settlement market. GWG, through its subsidiaries, purchases life insurance policies from seniors who no longer want, need or can afford their policies. GWG typically pays these seniors five to eight times more than the cash surrender values paid by insurance companies. GWG's strategy is to efficiently source, own, and manage these non-correlated assets at yields that exceed the costs needed to purchase and finance the policies (in aggregate). GWG finances the purchase and maintenance of a portfolio of policies primarily through a fixed income alternative investment product that is offered through independent broker-dealers and registered investment advisors across the country. GWG's goal is to generate financial returns for GWG's investors and shareholders while providing valuable financial solutions to seniors.

Hasco Medical Inc.
Hasco Medical Inc. (HASC)   Presenting on Day 2
Industry Sector: Retail and Consumer Products

HASCO Medical is a leading provider of wheelchair accessible vehicles, parts, and service that dramatically improve the quality of living of its customers. Founded in 2008, HASCO Medical is headquartered in Addison, TX. The company operates 20 locations in 11 states from Maine to Florida. The company's mobility brands include Ride-Away (, Mobility Freedom ( and Wheelchair Vans of America (, Inc., Inc. (HEWA)   Presenting on Day 1
Industry Sector: Technology - Media and Internet, Inc. operates as a virtual retail pharmacy and healthcare e-commerce company that sells brand name and generic prescription drugs, as well as over-the-counter (OTC) medical products in the United States. The company sells a range of prescription drugs; diabetic supplies, including glucometers, lancets, syringes, and test strips; and OTC medications covering a range of conditions from allergy and sinus to pain and fever to smoking cessation aids. It also offers home medical supplies, such as incontinence supplies, first aid kits, and mobility aids; and diet and nutritional products comprising supplements, weight loss aids, and vitamins and minerals. In addition, the company operates as a licensed mail-order pharmacy for sales to 50 states and the District of Columbia. It sells its products directly to the individual consumers of the pharmaceutical and non-pharmaceutical products. The Company is headquartered in Florence, Kentucky.

Heat Biologics, Inc.
Heat Biologics, Inc. (HTBX)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Heat Biologics, Inc. is a clinical-stage biopharmaceutical company focused on developing its novel, "off-the-shelf" ImPACT� therapeutic vaccines to combat a wide range of cancers. Our ImPACT� Therapy is designed to deliver live, genetically-modified, irradiated human cells which are reprogrammed to "pump out" a broad spectrum of cancer-associated antigens together with a potent immune adjuvant called "gp96" to educate and activate a cancer patient's immune system to recognize and kill cancerous cells. Heat is conducting a Phase 2 trial of its viagenpumatucel-L (HS-110) in patients with non-small cell lung cancer as well as a Phase 2 trial with its vesigenurtacel-L (HS-410) in patients with non-muscle invasive bladder cancer.

Hemispherx Biopharma, Inc.
Hemispherx Biopharma, Inc. (HEB)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Hemispherx Biopharma, Inc., headquartered in Philadelphia, Pennsylvania, is a biopharmaceutical company dedicated to treating and preventing chronic viral and immune-based disorders through the development and manufacturing of compounds that enhance the natural immune system of the human body.

The Company’s flagship products include Alferon N Injection® and the experimental immunotherapeutics Ampligen®. Its platform technology includes large and small agents for potential treatment of various chronic viral infections.

Highpower International, Inc.
Highpower International, Inc. (HPJ)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Highpower International was founded in 2001 and produces high-quality lithium and Nickel-Metal Hydride (Ni-MH) rechargeable batteries and battery systems used in a wide range of applications in the areas of mobile and wearable devices, electric transportation, residential and grid energy storage, and consumer and industrial products. The company is also developing emerging applications such as drones, robotics, and wireless charging technologies. With advanced manufacturing facilities located in China, and over 100 patents in battery materials, processing, and designs, Highpower is committed to clean technology, as well as environmental production process. Highpower's target customers are Fortune 500 companies and top 10 companies in each vertical segment. The majority of Highpower's products are distributed to worldwide markets mainly in the United States, Europe, China and Southeast Asia.

hopTo Inc.
hopTo Inc. (HPTO)   Presenting on Day 1
Industry Sector: Technology - Media and Internet

Founded in its current form in 2012, hopTo Inc. is an innovator of a unique mobile productivity workspace platform. The hopTo mobile solution delivers an unparalleled user experience without compromising enterprise security. hopTo brings a new standard of mobile productivity by enabling individuals to Search, Access, Create, Edit and Share content from their mobile devices, efficiently and effectively, by leveraging any combination of on-premise or cloud stored content, documents and data as well as enterprise applications. The company is based in Campbell, CA.

Immune Pharmaceuticals Inc.
Immune Pharmaceuticals Inc. (IMNP)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Immune Pharmaceuticals Inc (NASDAQ: IMNP). applies a personalized approach to treating and developing novel, highly-targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company's lead product candidate, bertilimumab, is in clinical development for moderate to severe ulcerative colitis and Crohn's disease as well as bullous pemphigoid, an orphan auto-immune dermatological condition. Immune licensed worldwide rights for systemic indications of bertilimumab from iCo Therapeutics (TSX: ICO; OTCQX: ICOTF) in June 2011, while iCo retained rights to all ophthalmic indications. iCo originally licensed the exclusive world-wide rights to bertilimumab in 2006 from MedImmune, the Global Research and Development arm of AstraZeneca. Immune's pipeline also includes NanomAbs®, antibody nanoparticle conjugates, for the targeted delivery of chemotherapeutics, and AmiKet™, a Neuropathic Pain drug candidate ready for Phase III. AmiKet has received Orphan Drug Designation for Post-Herpetic Neuralgia.

ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics, Ltd. (IMUC)
Industry Sector: Healthcare and Life Sciences

ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes: ICT-121, a dendritic cell vaccine targeting CD133; ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer killing T-cells.

ImmunoVaccine Inc.
ImmunoVaccine Inc. (IMMVF)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Immunovaccine has advanced two T cell activation therapies for cancer through Phase 1 human clinical trials and is currently conducting a Phase 2 study with its lead cancer vaccine therapy, DPX-Survivac, in recurrent lymphoma. DPX-Survivac is expected to enter additional Phase 2 clinical studies in ovarian cancer and glioblastoma (brain cancer). The Company is also advancing an infectious disease pipeline including innovative vaccines for respiratory syncytial virus (RSV) and anthrax.

Implant Sciences
Implant Sciences (IMSC)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company's team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, the QS-B220 desktop explosives and drugs trace detector and the QS-H150 handheld explosives trace detector, thousands of which have been sold across more than 60 countries worldwide. The Company's ETDs have received approvals and certifications from a number of international regulatory agencies, including the TSA in the U.S., ECAC in Europe, CAAC and the Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the Interior. It has also received the GSN Homeland Security Award for "Best Explosives Detection Solution" two years in a row (2013 and 2014). All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security.

Innate Immunotherapeutics Ltd
Innate Immunotherapeutics Ltd (ASX:IIL IMNP)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Innate Immunotherapeutics has a Phase 2B drug candidate to treat secondary progressive multiple sclerosis (“SPMS”). There are currently no safe and effective ongoing treatments for this highly disabling form of multiple sclerosis. Completed Phase 1B/2A trials have demonstrated excellent safety and tolerability. Many treated patients have self-reported significant improvements to disabilities caused by their disease.

A placebo controlled Phase 2B efficacy trial is currently enrolling patients in Australia and New Zealand. On completion of this study, mid 2016, the Company intends to partner with ‘big pharma’ to complete approval trials and enter the unmet US$3 billion SPMS market in the US and Europe.

The Company's core technology, a microparticle based immune modulator, has a number of other potential and important therapeutic applications which are being collaboratively evaluated by leading researchers in the US, Australia, Japan, Korea, and Taiwan. Innate Immunotherapeutics has offices in Sydney (Australia), and Auckland (New Zealand) and is listed on the Australian Securities Exchange (ASX) under the ticker "IIL". The Company's stock is currently held about equally by investors in the U.S., Australia, and New Zealand with the major shareholder (19%) being a NY based private investor. In addition, the U.S. National MS Society is the company's sixth largest shareholder.

Innovative Life Sciences Inc.
Innovative Life Sciences Inc. (Private)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Innovative Life Sciences, Inc. develops and commercializes award winning life sciences solutions using genomics & advanced drug delivery technologies. The Company has diversified global revenue opportunities from technology licensing of OTC and Rx therapeutic products and SaaS-related revenue from clinical genomics offerings.

Innovus Pharmaceuticals, Inc.
Innovus Pharmaceuticals, Inc. (INNV)
Industry Sector: Healthcare and Life Sciences

Innovus Pharmaceuticals, Inc. is an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective non-prescription over-the counter, medicine and consumer care products to improve men’s and women's health and vitality and treat respiratory diseases.

Headquartered in San Diego, Innovus Pharma is an emerging leader in over-the counter consumer products for men's and women’s health and vitality and respiratory diseases, and has a total of five marketed products in this space. The Company’s products include: Zestra® clinically proven to increase arousal and desire in women, EjectDelay® for premature ejaculation, Sensum+® (for sales outside the U.S. only) to treatthe indication of penile sensitivity, Zestra Glide® a low viscosity water based lubricant, Vesele® for increasing blood flow to enhance sexual and mental health and Androferti® to Support Overall Male Reproductive Health and Sperm Quality.

The Company recently announced that it acquired the worldwide rights to the Fluticare(TM) brand (Fluticasone propionate nasal spray) from Novalere FP., Inc. ("Novalere") through a merger allowing the Company to enter the over the counter nasal steroid market .

Interleukin Genetics, Inc.
Interleukin Genetics, Inc. (ILIU)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Interleukin Genetics, Inc. develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance.

IntriCon Corporation
IntriCon Corporation (IIN)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature and micro-miniature body-worn devices. These advanced products help medical and healthcare companies meet the rising demand for smaller, more intelligent and better connected devices.

The next phase of IntriCon’s long-term strategy is to leverage the company’s technology, product platforms and manufacturing capabilities in two large healthcare opportunities: the value hearing health (VHH) market�where IntriCon will work to bring additional low-cost and effective devices to consumers; and, the medical biotelemetry market�connecting people with caregivers through technology.

The company’s leadership position in VHH and medical biotelemetry is exemplified by its relationships with Medtronic, where it is the primary supplier of Medtronic’s continuous glucose monitors and hi HealthInnovations (a UnitedHealth Group company) as their exclusive supplier of hearing aids.

IntriCon has facilities in the United States, Asia and Europe.

Invent Ventures, Inc.
Invent Ventures, Inc. (IDEA)  

Industry Sector: Technology - Media and Internet

Inventergy Global, Inc.
Inventergy Global, Inc. (INVT)   Presenting on Day 1
Industry Sector: Technology - Media and Internet

Inventergy Global, Inc. is a Silicon Valley based intellectual property company dedicated to identifying, acquiring and licensing the patented technologies of market-significant technology leaders. Led by IP industry pioneer and veteran Joe Beyers, the Company utilizes decades of corporate experience, market and technology expertise, as well as industry connections to assist Fortune 500 companies in leveraging the value of their innovations to achieve greater returns. Inventergy creates value for select corporations through the monetization of their IP assets by building on the program that proved to be very successful at Hewlett Packard. Inventergy seeks to realize the appropriate ROI for their innovations. It represents a unique investment opportunity, positioned at the convergence of expertise, execution and assets. The Company has acquired key patent assets from some of the largest technology companies in the world including Huawei, Nokia and Panasonic, and now has a portfolio of more than 760 patent assets globally. Inventergy understands the challenges of leveraging IP assets and also plays a key role in shaping the future of intellectual property industry.

Iveda Solutions
Iveda Solutions (IVDA)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Iveda Solutions enables cloud video surveillance via its Sentir™ Software as a Service (SaaS) video management platform, utilizing proprietary video streaming and Big Data storage technology. Iveda enables a recurring revenue model by licensing Sentir to service providers (e.g., telecoms, ISPs, data centers, cable companies) for plug-and-play cloud video offering to their customers. Iveda Solutions has a SAFETY Act Designation by the Department of Homeland Security as a Qualified Anti-Terrorism Technology provider.

Juniper Pharmaceuticals
Juniper Pharmaceuticals (JNP)   Presenting on Day 2
Industry Sector: Industrials

Juniper Pharmaceuticals is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in women's health. The company has a successful heritage in developing pharmaceutical products for this market, including CRINONE® 8% (progesterone gel), which is marketed by Actavis, Inc. in the U.S. and by Merck Serono S.A. in over 60 countries worldwide.

Juniper is accelerating development of its proprietary product pipeline, leveraging in-house formulation, pharmaceutical development, and manufacturing.  R&D is substantially funded by cash flow generated by the CRINONE franchise and the contract pharmaceutical services provided by Juniper Pharma Services.  In Q2 2015, the company is poised to initiate a Phase II study of COL-1077, a 10% lidocaine bioadhesive gel intended as an acute use anesthetic for minimally invasive gynecologic procedures.  Future pipeline products will utilize Juniper’s novel drug delivery technologies, including its proprietary bioadhesive delivery system (BDS) and a segmented intra-vaginal ring (IVR) developed in the laboratories of Dr. Robert Langer at the Massachusetts Institute of Technology and Dr. William Crowley at Massachusetts General Hospital and Harvard Medical School.

KonaRed Corporation
KonaRed Corporation (KRED)  

Industry Sector: Retail & Consumer Products

Lantronix, Inc.
Lantronix, Inc. (LTRX)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Lantronix, Inc. is a specialized networking company providing M2M (machine to machine) and IoT (Internet of Things) solutions. Our products deliver secure connectivity, device management and mobility for today's increasingly connected world. By networking and managing devices and machines that have never before been connected, we enable our customers to realize the possibilities of the Internet of Things. Founded in 1989, Lantronix pioneers robust, intelligent and easy to deploy solutions for mission critical applications in a wide range of industries, including data center, medical, security, industrial, transportation, retail, financial and government. Lantronix is headquartered in Irvine, California, with offices in Europe, Asia and Japan.

Latitude 360, Inc.
Latitude 360, Inc. (LATX)
Industry Sector: Industrials

Latitude 360, is an award-winning pioneer of combining premier upscale casual dining with state-of-the-art entertainment creating a “360 Experience” in its unique venues. The Company develops, constructs and operates cutting-edge Latitude 360 locations (from 35,000-85,000 sq. ft.) that appeal to a broad base of consumers and corporate clients. Its three current award-winning locations are based in Jacksonville, FL, Pittsburgh, PA and Indianapolis, IN, more locations opening in the next several months in large markets like New York and Massachusetts.

LeMaitre Vascular Inc.
LeMaitre Vascular Inc. (LMAT)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

LeMaitre Vascular, Inc. is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart.

Lilis Energy, Inc.
Lilis Energy, Inc. (LLEX)   Presenting on Day 2
Industry Sector: Energy and Natural Resources

Lilis Energy, Inc. is a Denver-based independent oil and gas exploration and production company that operates in the Denver-Julesburg (DJ) Basin, where it holds approximately 40,100 gross, 39,000 net acres. Lilis Energy's near-term E&P focus is to pursue strategic acquisitions and grow current reserves and production in its Wattenberg Field acreage targeting the Niobrara benches and Codell Sandstone.

Lomiko Metals Inc.
Lomiko Metals Inc. (LMRMF)   Presenting on Day 1
Industry Sector: Technology - Media and Internet

Lomiko Metals Inc. is a Canada-based, exploration-stage company. It is engaged in the development of technology and minerals for the new green economy. Currently, its mineral properties include the Quatre Milles graphite property and the Vines Lake property. Lomiko also has an option to earn an 80% interest in the La Loutre graphite property through a joint venture agreement with Canada Strategic Metals.

Futhermore, Lpmiko is invested in graphene technologies through Graphene 3D Lab, owning 10.43% (4.4 million shares), a start-up company that would use graphene-enhanced plastic to print electrically conductive materials from a 3D printer. The company filied a provisional patent application for some of its processes in January 2014. On October 23, 2014, Graphene 3D Lab announced it had reached a significant milestone by printing a battery using a 3D printer. On December 3rd, Lomiko entered into its second graphene start-up through investing $200,000 for 40% of Graphene ESD (Energy Storage Devices).

MamaMancini's Holdin
MamaMancini's Holdin (MMMB)   Presenting on Day 2
Industry Sector: Retail and Consumer Products

MamaMancini's is a marketer and distributor of a line of all natural, beef meatballs with sauce, turkey meatballs with sauce, chicken meatballs with sauce, pork meatballs with sauce, and other similar Italian products. The Company's sales have been growing on a consistent basis as the Company expands its distribution channel, which includes major retailers such as Costco, Publix, Shop Rite, Price Chopper, A&P, Waldbaums, Food Emporium, Harris Teeter, SaveMarts, Luckys, Lunds/Byerly's, SuperValu, Raley's, BJ's, Whole Foods, Shaw's Supermarkets, Kings, Key Foods, Stop-n-Shop, Giant Stores, Giant Eagle, Food Town, Kroger, Winn Dixie Shoppers, Wal-Mart, Marsh's Supermarkets, Bi-Lo, Central Markets, Weis Markets, Ingles, and The Fresh Market.

Mantra Venture Group Ltd.
Mantra Venture Group Ltd. (MVTG)   Presenting on Day 1
Industry Sector: Energy and Natural Resources

Mantra Venture Group Ltd. is a clean technology incubator that takes innovative emerging technologies and moves them towards commercialization. Through its subsidiaries, Mantra is currently developing two groundbreaking, environmentally beneficial electrochemical technologies ERC (Electro-Reduction of Carbon Dioxide) and MRFC (Mixed-Reactant Fuel Cell).

ERC is a form of “carbon capture and utilization” (CCU) that converts the polluting greenhouse gas carbon dioxide into useful, valuable products including formic acid and formate salts. By utilizing clean electricity, the process offers the potential for an industrial plant to reduce emissions while generating a salable product and a profit.

The MRFC is an unconventional fuel cell that uses a mixture of fuel and oxidant, thereby greatly reducing the complexity and cost of the fuel cell system. Ideal for portable applications, the MRFC is cheaper, lighter, and more compact than conventional fuel cell technologies.

Presenting Company Sponsor

MassRoots, Inc.
MassRoots, Inc. (MSRT)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

MassRoots is one of the largest and most active social networks for the cannabis community with 275,000 users. People use our app to find smoking buddies, share their cannabis experiences and stay connected with local dispensaries. MassRoots has been covered by CNN, CNBC, Fortune, BBC and the New York Times.

Presenting Company Sponsor

Medbox, Inc.
Medbox, Inc. (MDBX)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Medbox provides specialized consulting services to the marijuana industry and sells associated patented products, including its Medbox medical dispensing system and medical vaporization devices. The company works with clients who seek to enter the medical, recreational and cultivation marijuana markets in those states where approved. Medbox offers turnkey solutions that assist with licensing and compliance, site selection, design and permitting, safety and security, along with full build-out and operational oversight. Medbox’s consulting solutions and technology create structure and process for clients and their respective businesses in this rapidly emerging sector.

Medical Transcription Billing Corp.
Medical Transcription Billing Corp. (MTBC)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

MTBC went public in July 2014, purchasing the assets of three medical billing companies for a combination of cash and stock on the date the IPO closed. These have now been successfully integrated with its existing business. In the same way that athenahealth (Nasdaq: ATHN) currently dominates the healthcare information technology market for large doctor practices, MTBC is targeting the fragmented 1-10 doctor market, with a highly-rated proprietary SaaS platform that integrates revenue cycle management with electronic health records, practice management and mobile health.

New government regulations like ICD-10 are putting pressure on industry participants who lack our technology and access a low cost offshore workforce. 95% of our current global workforce of 2,000 is located in Pakistan, where labor costs are approximately 1/2 the cost of comparable India-based employees and 1/10th the cost of comparable U.S. employees. Our growth strategy includes acquiring such revenue cycle management companies and migrating their customers to our platform, as well as forging strategic partnerships with other industry participants, including electronic health records vendors.

MedOfficeDirect Private   Presenting on Day 2
Industry Sector: Technology - Media and Internet

MedOfficeDirect is a technology company in the healthcare distribution market space. Our technology is the 1st in-class virtual distributor of medical supplies for the $12 billion non-acute supply chain market. MOD is the go-to virtual distributor for Group Purchasing Organizations (GPOs) to ensure complete transparency and best prices for their non-acute members. Our business model, strategic partnerships, and industry expertise lowers the overall cost of healthcare while delivering a bundled value proposition for physicians to spend more clinical time with their patients.

Merchant Cash and Capital
Merchant Cash and Capital Private   Presenting on Day 2
Industry Sector: Software and Business Services

Since its founding in 2005, Merchant Cash and Capital (MCC) and its family of companies has originated more than $1 Billion for over 20,000 businesses across the United States.  MCC has funded nearly every type of industry including restaurants, franchises, retailers, health service providers, auto service and many others to get the capital they need to move their businesses forward.  MCC is both a balance sheet funding company and an aggregation platform (Bizfi).

Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Milestone Scientific Inc. is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless.

Multimedia Platforms Inc.
Multimedia Platforms Inc. (MMPW)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Multimedia Platforms Inc. ("MMP") is a publicly traded industry-leading Multimedia Technology and Publishing company that integrates print media with social media, and related online platforms, to deliver information and advertising to niche markets. MMP teams utilize its proven business model to deliver niche publications and online platforms that target one of the most sought-after demographics in the world, the Lesbian, Gay, Bisexual and Transgender population. MMP has recently expanded its concept to include video and mobile applications reaching deep into the international LGBTQ community. MMP's top brands include The Agenda, a Florida-based weekly LGBTQ newspaper covering world, national and local news and events; and Guy Magazine, a weekly entertainment and lifestyle full-color publication covering the burgeoning South Florida LGBTQ marketplace. MMP's plan to interweave print, web and mobile delivery of the highest quality news and entertainment information via a variety of platforms crosses all cultural, generational and preferred modality barriers to reach an unprecedented audience.

NAC Global Technologies
NAC Global Technologies (NACG)   Presenting on Day 2
Industry Sector: Industrials

NAC Global Technologies (NAC) is a development and manufacturing company operating in the robotics, automation, energy, defense, and medical industries. NAC focuses on supplying critical technologies to meet key national and global needs in existing and emerging multi-billion dollar markets. Its wholly owned subsidiary, NAC Drive Systems, is a supplier of Harmonic Gearing Technology, which is critical in applications requiring high precision motion control, reliability and long life including national defense uses. Expanding from this market entrance point, the company is building a portfolio of synergistic technologies to expand its market and application reach into emerging advanced force sensing robotics and clean energy technologies and has a strategic initiative in place to commercialize a new Aluminum Air Fuel Cell. The new fuel cell technology is non-hazardous, recyclable, has a high power to weight ratio, is none volatile, and is scalable for use in portable, vehicle, aircraft, spacecraft, and emergency home, business and remote locations. The Company has its headquarters in Jacksonville, FL and manufacturing, warehousing, and offices in Port Jervis, NY and is partnered with the HGT supplier to the China Space Agency.

NanoViricides, Inc.
NanoViricides, Inc. (NNVC)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

NanoViricides, Inc., in a pre-clinical biotech company developing anti-viral drugs to destroy a wide range of viruses in and on the body as well as in the eye. The Company has developed a platform technology, based on the principles of nanotechnology, that enables rapid drug development either in the lab or in the field.

The Company has successfully treated 5000 animals after infection with a wide range of viral diseases. These include all forms of influenza, HIV/AIDS, herpes of the genitals and the eye, adenovirus of the eye, dengue and dengue hemorrhagic fever, rabies and Ebola.

Construction of a new facility and pilot production plant has been completed and Human trials for FluCide®, our drug for complicated influenza in hospitalized patients, is now planned for the first half of 2016.

The Company is well funded and currently actively trades on the NYSE:mkt with a market cap of $150M.

Napco Security Technologies, Inc.
Napco Security Technologies, Inc. (NSSC)   Presenting on Day 2
Industry Sector: Industrials

NAPCO Security Technologies, Inc. is one of the world's leading solutions providers and manufacturers of high-technology electronic security, connected home, video, fire alarm, access control and door locking systems. The Company consists of four Divisions: NAPCO, its security and connected home segment, plus three wholly-owned subsidiaries: Alarm Lock, Continental Instruments, and Marks USA. Headquartered in Amityville, New York, its products are installed by tens of thousands of security professionals worldwide in commercial, industrial, institutional, residential and government applications. NAPCO products have earned a reputation for innovation, technical excellence and reliability, positioning the Company for growth in the multi-billion dollar and rapidly expanding electronic security market.

National Waste Management Holdings, Inc.
National Waste Management Holdings, Inc. (NWMH)   Presenting on Day 2
Industry Sector: Industrials

National Waste Management Holdings Inc., through its subsidiary, Sand/land of Florida Enterprises Inc., is a leading Construction and Demolition (C&D) landfill in Hernando, Florida servicing Citrus, Hernando, and Marion counties and is the distinguished leader in landfill services on Florida's west coast.

Nemaura Medical Inc.
Nemaura Medical Inc. (NMRD)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Nemaura Medical Inc. is developing smart non-invasive medical diagnostic devices for the global healthcare market. Their first product is a painless, minimally invasive Continuous Glucose Monitoring solution targeting diabetics called  ‘sugarBEAT’. This consists of a disposable sensor patch that is worn around the arm or thigh, connected to a watch device. The sugarBEAT system has so far completed a 100 patient day clinical study and is anticipated for CE approval and launch in the UK and Saudi Arabia by early 2016. The company is exploring a range of other analytes for continuous monitoring purposes using their platform technology.

Nemus Bioscience, Inc.
Nemus Bioscience, Inc. (NMUS)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

NEMUS Bioscience is a biopharmaceutical company focused on developing cannabis-derived pharmaceuticals to address unmet needs on a worldwide basis. We are the sole commercial partner of the University of Mississippi, the only entity authorized by the federal government to cultivate cannabis for research purposes. Our lead compound, NB1111 (an NCE; patent issued in August, 2014), is being developed for the treatment of glaucoma. Pre-clinical results have been encouraging. We are also developing treatments for MRSA, anxiety and epilepsy. NEMUS has brought together a team deep in biotech, pharmaceutical, and public company experience to lead the FDA review process

Neostem Inc.
Neostem Inc. (NBS)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

NeoStem is a biopharmaceutical company pursuing the preservation and enhancement of human health globally through the development of novel cell based personalized medicine therapeutics that prevent, treat or cure disease. The Company is developing therapies based on three platform technologies (immune-oncology, ischemic repair and immunomodulation) with a lead, late-stage (Phase 3, 2 and 2, respectively) clinical program for each. The combination of a rich therapeutics pipeline and an externally recognized in-house center for cell therapy process development and manufacturing has created an organization with unique capabilities for accelerated and efficient product development.

Nephros, Inc.
Nephros, Inc. (NEPH)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. Nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins.

Nephros was founded in 1997, by healthcare professionals affiliated with Columbia University Medical Center, initially to address the needs of chronic renal failure patients.

The company has developed an alternative to current hemodialysis therapy known as Mid-dilution hemodiafiltration (mid-HDF). Nephros’ proprietary blood purification technologies enable mid-HDF to be offered to chronic renal failure patients. Nephros mid-dilution filters remove a range of harmful substances, specifically substances known as middle molecules, which have been linked to conditions such as carpal tunnel syndrome, dialysis related amyloidosis, and degenerative bone disease in chronic renal failure patients.

Nephros has extended its filtration technologies to meet the demand for liquid purification in other areas, in particular water purification. Nephros is currently developing its filter technology in individual water purifiers for military applications.

Net Element, Inc.
Net Element, Inc. (NETE)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Net Element is a payment-as-a-service technology company focused on enabling payments for global commerce. The Company operates a value-added transaction processing division in the US and a mobile payments division in Russia. The Company entered into a binding term sheet to acquire PayOnline, a market leader in online payments in the Russian Federation, Europe and Asia. In 2015 the Company contemplates growth by expanding product offerings and geographic reach organically and through partnerships.

Neurovive Pharmaceutical AB
Neurovive Pharmaceutical AB Private   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

NeuroVive Pharmaceutical AB carries out research and development into pharmaceuticals that protect the mitochondria. The company’s drug development technology platform comprises cyclosporine A and molecules with a different chemical structure that protect the mitochondria by inhibiting enzymes of the cyclophilin class. NeuroVive’s project portfolio contains clinical programs offering protection against reperfusion injury after myocardial infarction, phase III, and neuroprotectants in connection with traumatic brain injury, phase II. In addition, NeuroVive is working on a number of other projects relating to neuroprotection and energy regulation in mitochondrial disease.

Newtek Business Services, Inc.
Newtek Business Services, Inc. (NEWT)   Presenting on Day 2
Industry Sector: Software and Business Services

Newtek Business Services Corp, The Small Business Authority®, is an internally managed BDC, which along with its controlled portfolio companies, is a direct distributor of a wide-range of business services and financial products to the small- and medium-sized business market (SMB). Publically traded since September 2000, it has provided state-of-the-art, cost-efficient products and services and efficient business strategies to over 100,000 SMB accounts across all 50 States. Newtek provides the following services to independent business owners: SBA 7(a) and SBA 504 Lending, Receivable and Inventory Line of Credit Financing, Electronic Payment Processing, eCommerce and Mobile Processing, Payroll Processing, Commercial / Personal Insurance /Health & Benefits, Cloud Computing Products and Web Services – Hosting/Design Development.

NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc. (NBY)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

NovaBay Pharmaceuticals is a biopharmaceutical company focusing commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. NovaBay has two distinct product categories: the NEUTROX™ family of products, led by AVENOVA™ for the eye care market, NEUTROPHASE® for wound care, and CELLERX™ for the dermatology market; and AGANOCIDE® compounds, led by AURICLOSENE™. NovaBay is commercializing AVENOVA, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. These difficult-to-manage conditions affect approximately 30 million Americans, with an annual market potential that NovaBay estimates at $500 million. NovaBay is gaining market traction with AVENOVAthrough its35-medical direct sales representatives under veteran leadership. AVENOVA is available for order in 90% of all pharmacies across the U.S. through distribution agreements with AmerisourceBergen, Cardinal Health and McKesson.

Novogen Limited
Novogen Limited (NVGN)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Novogen is a drug development company focused on bringing into the clinic novel therapeutics for degenerative diseases, cancer in particular. The Company has two proprietary drug technology platforms, each targeting novel drug targets within the cell: Super-benzopyrans (SBPs) and anti-tropomyosins (ATMs)

SBP compounds have been created to kill the full range of cells within a tumor, but particularly the cancer stem cells. The ATM compounds target the cytoskeleton of the cancer cell and when used in conjunction with standard anti-cytoskeleton drugs, result in comprehensive and fatal destruction of the cancer cell’s cytoskeleton.Ovarian cancer, colorectal cancer, malignant ascites, prostate cancer, neural cancers (glioblastoma, neuroblastoma) and melanoma are the key clinical indications being pursued, with the ultimate objective of employing both technologies as a unified approach to both first-line therapy and salvage therapies.

nUro, Inc.
nUro, Inc. (Private)
Industry Sector: Healthcare and Life Sciences

nUro, Inc. arose from the development of viable clinical programs acquired from Medtronic, developed via SBIR funding at Rosellini Scientific, and finalized via the acquisition of Synaptix, a vertically integrated medical device manufacturing company with a CE Marked deep brain stimulator. This 16-channel recording and stimulation platform has been deployed in clinical studies for the treatment of movement disorders and atrial fibrillation. In addition, the Company has developed a wireless version of the device for use in the peripheral nervous system, most notably the posterior tibial nerve for the treatment of urological disorders. nUro, Inc. has now produced and tested its device conforming to good manufacturing practice in its class 10,000 cleanroom. It is in the midst of a number of controlled clinical trials.

OncoSec Medical Incorporated
OncoSec Medical Incorporated (ONCS)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

OncoSec Medical Inc. is a biopharmaceutical company developing its investigational ImmunoPulse intratumoral cancer immunotherapy. OncoSec Medical's core technology is designed to enhance the local delivery and uptake of DNA IL-12 and other DNA-based immune-targeting agents. Clinical studies of ImmunoPulse have demonstrated an acceptable safety profile and preliminary evidence of anti-tumor activity in the treatment of various skin cancers, as well as the potential to initiate a systemic immune response without the systemic toxicities associated with other treatments. OncoSec's lead program evaluating ImmunoPulse for the treatment of metastatic melanoma is currently in Phase 2 development, and is being conducted in collaboration with several prominent academic medical centers. As the company continues to evaluate ImmunoPulse in its current indications, it is also focused on identifying and developing new immune-targeting agents, investigating additional tumor indications, and evaluating combination-based immunotherapy approaches.

One Horizon
One Horizon (OHGI)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

One Horizon developed a proprietary VoIP platform ("Horizon Platform") that enables wireless carriers around the world to provide customized and optimized voice and data services over any mobile, fixed and satellite network through an easy to install mobile App. Its SmartPacket™ technology underlying the Horizon Platform enables greater bandwidth efficiency by reducing IP overhead and optimizing packet flow, delivery and playback. One Horizon targets emerging markets with high population densities, high penetration of mobile phones, congested mobile networks, and high growth in smartphone adoption. In this context, it has formed strategic relationships with local partners in India, Russia and China.

Opexa Therapeutics
Opexa Therapeutics (OPXA)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Opexa Therapeutics, Inc. is a publically traded biotechnology company developing personalized immunotherapies with the potential to treat major illnesses, including multiple sclerosis (MS) as well as other autoimmune diseases, such as neuromyelitis optica (NMO). These therapies are based on Opexa�s proprietary T-cell technology. The Company�s leading therapy candidate, Tcelna�, is a personalized T-cell immunotherapy that is in a Phase IIb clinical development program (the Abili-T trial) for the treatment of Secondary Progressive MS

OptimizeRx Corporation
OptimizeRx Corporation (OPRX)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

OPTIMIZERx Corporation provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand awareness, access and adherence to their medications. Our core product, SampleMD, replaces drug samples with electronic trial vouchers and copay coupon savings that are electronically added to an e-Prescription and sent electronically to the pharmacy. OptimizeRx’s proprietary technology is already integrated into some of the largest Electronic Health Record (EHR) platforms in the country, including Allscripts, Quest Diagnostics, Practice Fusion and over 300 other EHRs to reach over 250,000 healthcare providers. In turn, we promote patients savings and support from the world’s largest pharmaceutical companies, including Pfizer, Lilly, Novartis, AstraZeneca and many others.

Patent Properties
Patent Properties (PPRO)   Presenting on Day 2
Industry Sector: Technology - Media & Internet

Patent Properties developed and recently introduced The United States Patent Utility�, a subscription-based service that uses proprietary Big Data software to connect the global stockpile of technology improvements and technical experts, represented by the U.S. patent database, with businesses that can put them into commercial uses that help them compete and grow. The Company also owns and seeks to commercialize, license and enforce the unique portfolio of intellectual property developed by inventor and entrepreneur Jay Walker, who serves as the Company's Executive Chairman. Mr. Walker is best known as the founder of and has twice been named by TIME magazine as "one of the top 50 business leaders of the digital age." Mr. Walker currently ranks as the world's 11th most patented living individual, based on U.S. patent issuances according to Wikipedia. Additional information regarding The U.S. Patent Utility can be found at

PC Connection Inc.
PC Connection Inc. (PCCC)   Presenting on Day 2
Industry Sector: Technology - Media and Telecommunications

We are a national solutions provider of a wide range of information technology, or IT, solutions. We help our customers design, enable, manage, and service their IT environments. We provide IT products, including computer systems, software and peripheral equipment, networking communications, and other products and accessories that we purchase from manufacturers, distributors, and other suppliers. We also offer services involving design, configuration, and implementation of IT solutions. These services are perfom1ed by our personnel and by third-party providers. We have three operating segments, which serve primarily: (a) small- to medium-sized businesses, or SMBs, in our SMB segment, through our PC Connection Sales subsidiary, (b) large enterprise customers, in our Large Account segment, through our MoreDirect subsidiary, and (c) federal, state, and local government and educational institutions, in our Public Sector segment, through our GovConnection subsidiary. We generate sales through (i) outbound telemarketing and field sales contacts by sales representatives focused on the business, educational, healthcare, and government markets, (ii) our websites, and (iii) inbound calls from customers responding to our catalogs and other advertising media. We offer a broad selection of over 300,000 products at competitive prices, including products from Apple, Cisco Systems, Dell, EMC, Hewlett Packard, IBM, Lenovo, Microsoft, Symantec, VMWare, and we partner with more than 1,600 suppliers. Our most frequently ordered products are carried in inventory and are typically shipped to customers the same day the order is received.

Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc. (PESI)   Presenting on Day 1
Industry Sector: Industrials

Perma-Fix Environmental Services, Inc. is a nuclear services company and leading provider of nuclear and mixed waste management services. The Company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the DOE, the Department of Defense ("DOD"), and the commercial nuclear industry. The Company’s nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The Company operates four nuclear waste treatment facilities and provides nuclear services at DOE, DOD, and commercial facilities nationwide.

PetVivo Holdings, Inc.
PetVivo Holdings, Inc. (PETV)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

PetVivo Holdings Inc. is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets and pet therapeutics. PetVivo believes that it can leverage investments in the human medical device industry to commercialize therapeutics for pets in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals.

PetVivo's strategy is to acquire or in-license proprietary products from human medical device companies specifically for the companion animal market. The company’s pipeline includes seventeen animal and human therapeutics. A portfolio of twenty patents protects the company’s products, production processes and biomaterials. PetVivo’s lead product, a veterinarian-administered joint injection for the treatment of osteoarthritis in dogs, is scheduled for commercial launch later this year.

PlasmaTech Biopharmaceuticals
PlasmaTech Biopharmaceuticals (PTBI)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

PlasmaTech Biopharmaceuticals, Inc. is a biopharmaceutical company focused on advancing targeted treatments for significant unmet needs of critical patient care. Exploiting two distinct proprietary platforms, PlasmaTech Bio is active in the development and commercialization of cancer supportive care products and plasma-derived therapeutics. The company has a robust product pipeline that includes: a novel plasma fractionation process, a proven patented drug delivery platform, two commercial stage products and multiple follow-on products in development.

PositiveID Corporation
PositiveID Corporation (PSID)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

PositiveID Corporation™ develops molecular diagnostic systems that use real-time polymerase chain reaction chemistry for bio-threat detection and rapid medical testing. The Company’s proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed under contract with the U.S. Department of Homeland Security Science & Technology directorate, and $30 million of contract funding. M-BAND continuously and autonomously analyzes air samples to detect biological airborne threats in the form of bacteria, viruses, and toxins. The Company’s Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results in less than 20 minutes. Firefly Dx is being developed to meet the growing need in healthcare and molecular diagnostics markets for handheld, real-time PCR testing, and thereby enabling hospitals, physicians and other providers to save lives and fight disease. PSID has offices in Delray Beach, Florida and Pleasanton, California.

Potbotics Inc.
Potbotics Inc. (N/A)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

While others are looking to make marijuana stronger, PotBotics is looking to make it smarter. Our diverse technology offering blends robotics, artificial intelligence, DNA analysis and cannabis research to address the major pain points in the medical marijuana industry, benefiting patients, physicians, cultivators and dispensary owners. Together our three products create an enterprise technology platform for medical marijuana.

Powerstorm ESS
Powerstorm ESS (PSTO)   Presenting on Day 1
Industry Sector: Energy and Natural Resources

Powerstorm ESS serves the growing demand for off-grid and microgrid energy storage systems worldwide, especially in emerging markets, effectively helping to bring power to the 1.3 billion people living in energy poverty with limited connection to the rest of the world. We offer environmentally friendly, power-agnostic, and turnkey power management and energy storage solutions of the highest quality such as our Modular Energy Storage Solution ("MESS"), and our residential/disaster recovery solution "zeroXess".

Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBIO)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Pressure BioSciences, Inc. (“PBI”) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular (e.g., nucleic acids, proteins, lipids) interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications.

Prospect Capital Corporation
Prospect Capital Corporation (PSEC)   Presenting on Day 2
Industry Sector: Software and Business Services

Prospect Capital Corporation is a financial services company that lends to and invests in private middle market companies, which typically have annual revenues of less than $750 million and enterprise values of less than $1 billion. Prospect’s investment objective is to generate both current income and long-term capital appreciation through debt and equity investments.

Pulse Evolution Corporation
Pulse Evolution Corporation (PLFX)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Pulse Evolution Corporation (“Pulse”) is a creatively driven, digital production and IP Company, established to produce specialized, high-impact applications of computer-generated human likeness for utilization in entertainment, life sciences, education and telecommunication. Founded by the world’s leading producers of photorealistic digital humans, Pulse develops “virtual humans” for live and holographic concerts, advertising, feature films, branded content, medical applications and training. Pulse is headquartered in Port St. Lucie, Florida.

PURE Bioscience, Inc.
PURE Bioscience, Inc. (PURE)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products -- primarily as a food safety solution for the food industry. PURE® Hard Surface disinfectant has begun to generate initial revenues: (a) as part of a controlled sales rollout to the franchisees of the nearly 27,000 SUBWAY® locations in the U.S. and, (b) in sales to food manufacturers/processors. We are in various stages of protocol development/testing with additional restaurant chains and processors. “Protecting Your Brand,” PURE Hard Surface disinfectant is a uniquely effective solution to the health and environmental challenges of pathogen and hygienic control. Initial products are based on patented, stabilized ionic silver, Silver Dihydrogen Citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent manufactured as a liquid and delivered in various concentrations. SDC-based disinfecting and sanitizing products are EPA registered. We are well on our way developing a third revenue channel -- seeking FDA approval for SDC for use in direct food contact. Current resources are primarily focused on providing food safety solutions – and we will continue to license the technology platform for other industries. PURE is headquartered in El Cajon, California (San Diego metropolitan area).

QUSA International, Inc.
QUSA International, Inc. (Private)   Presenting on Day 1
Industry Sector: Industrials

QUSA's business is comprised of (1) its India based subsidiary (IndiaCo) and (2) the distribution and resale of IndiaCo products in the US and other international markets. QUSA's products for the automotive and engine markets are used to manage engine heat, lower operational costs and reduce harmful emissions in vehicles and any other equipment powered by diesel, gasoline and natural gas. IndiaCo designs, manufactures, and sells surface applied thermal products under the brand name Q-Shield™ to OEMs serving the Indian automotive market and for other industrial applications.

IndiaCo is a Tier 1 supplier to large multinational automotive and engine companies in India and is ranked as one of the top performing suppliers by these large multinationals. QUSA operates in large and growing domestic and international markets. Management believes that government mandated environmental restrictions on harmful emissions will continue to drive the demand for QUSA products worldwide. The automotive market in India is dynamic and growing and is expected to develop into the largest automotive market in the world. QUSA technology is high quality, low cost, and has important competitive advantages. QUSA is a growing and profitable company with a proven business model guided by experienced management in the US and India.

Relmada Therapeutics Inc.
Relmada Therapeutics Inc. (RLMD)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Relmada Therapeutics is a clinical-stage, publicly traded biopharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. The Company has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol.

RestorGenex (RESX)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

RestorGenex is a specialty biopharmaceutical company focused on developing a portfolio of first-in-class therapeutic products to treat diseases across the ophthalmologic, oncologic and dermatologic space. RestorGenex’s lead product is a novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in pre-clinical development for glioblastoma multiforme. The current pipeline also includes a “soft” anti-androgen compound for the treatment of acne vulgaris. RestorGenex’s novel inhibition of the PI3K pathway and unique targeting of the androgen receptor show promise in a number of additional diseases, which the Company is evaluating for the purpose of creating safe and effective treatments and innovative therapies.

Revive Therapeutics Ltd.
Revive Therapeutics Ltd. (RVV)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Revive Therapeutics Ltd. is a clinical-stage company focused on commercializing treatments for gout (Phase 2a in the U.S.) and orphan drug indications such as Cystinuria, Wilson disease and Rett syndrome.

RiceBran Technologies
RiceBran Technologies (RIBT)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

RiceBran Technologies is a human food ingredient and animal nutrition company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. Rice Bran Technologies has proprietary and patented intellectual property that allows us to convert rice bran, one of the world's most underutilized food sources, into a number of highly nutritious human food ingredient and animal nutrition products. Our target markets are human food ingredients and animal nutrition manufacturers and retailers, as well as natural food, functional food and nutraceutical supplement manufacturers and retailers, both domestically and internationally.

ROI Land Investments
ROI Land Investments (ROII)
Industry Sector: Financial Services & Asset Management

ROI Land Investments Ltd. ("ROI") is a Real Estate Investment Company specializing in Land Development. ROI`s business model consists of acquiring attractive land developments free of zoning restrictions, obtaining the necessary development permits, outsourcing the development of the infrastructure and profiting from the sale of the subdivided land units to known large regional developers.

Rosewind Corporation
Rosewind Corporation (RSWN)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Rosewind Corporation is a specialty healthcare company focused on redox-modulated conditions, with an initial focus on developing treatments for urological and related conditions. The Company is currently initiating Phase 3 clinical development for its lead therapeutic candidate Zertane™, an orally disintegrating tablet (ODT) formulated specifically for the on-demand treatment of premature ejaculation (PE). The Company’s therapeutic pipeline is supported in part by its first-in-class RedoxSYS® System provides the only complete assessment of patients’ redox status and enables identification of a broad variety of disorders where redox is implicated. Initial studies are underway utilizing the RedoxSYS system in male fertility. The Company’s strategy is to develop its core therapeutic and diagnostic assets while building an innovative pipeline of established marketed products and late-stage development assets. The company expects to change its name to Aytu BioScience in the near future.

Sajan Inc.
Sajan Inc. (SAJA)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Publicly traded and headquartered in River Falls, Wisconsin, Sajan is a leading full-service translation and localization solutions and technology provider. The company helps many of the world’s leading brands - across life sciences, consumer brands, manufacturing, high tech and other industries - reach new markets and increase share in existing ones. Covering 130+ languages, Sajan’s services span translation, transcreation, website and software localization, global marketing, multilingual SEO and more. The company has seen nine consecutive quarters of revenue growth and continues to expand its teams across its offices in the U.S., Ireland, Spain and Singapore.

SANUWAVE Health, Inc.
SANUWAVE Health, Inc. (SNWV)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

SANUWAVE Health, Inc. is a shock wave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. SANUWAVE’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses, producing new vascularization and microcirculatory improvement, which helps restore the body’s normal healing processes and regeneration. SANUWAVE applies its patented PACE technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Its lead product candidate for the global wound care market, dermaPACE®, is CE Marked throughout Europe and has device license approval for the treatment of the skin and subcutaneous soft tissue in Canada, Australia and New Zealand. In the U.S., dermaPACE is currently under the FDA’s Premarket Approval (PMA) review process for the treatment of diabetic foot ulcers. In addition, there are license/partnership opportunities for SANUWAVE’s shock wave technology for non-medical uses, including energy.

SG Blocks
SG Blocks (SGBX)   Presenting on Day 1
Industry Sector: Industrials

SG Blocks is the premier innovator of commercial and private environments utilizing code-engineered cargo shipping containers. Providing solutions to some of the world's biggest companies and government agencies, SG Blocks offers cost effective container-construction technology that exceeds many standard building code requirements. The Company works with developers, architects, builders and owners to achieve faster execution, stronger high-value buildings, and greener construction.

SilverSun Technologies
SilverSun Technologies (SSNT)   Presenting on Day 1
Industry Sector: Technology - Media and Internet

SilverSun Technologies is a business application and technology provider to small and medium-sized businesses (“SMB’s”). As a value-added reseller, the Company sells and implements Enterprise Resource Planning, Warehouse Management, and Business Intelligence solutions.The Company also publishes twenty proprietary software applications, including its award-winning MAPADOC EDI (Electronic Data Interchange) solution. In addition, the Company is a Managed Service Provider (“MSP”), providing 24/7/365 remote monitoring of its clients networks, business continuity, disaster recover, data backup, and application hosting.

Sino Mercury Acquisition Corp.
Sino Mercury Acquisition Corp. (SMAC)   Presenting on Day 2
Industry Sector: Financial and Asset Management Services

Sino Mercury Acquisition Corp. is a blank check company formed for the purpose of entering into a stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region of the world although we initially intend to focus on target businesses in the People’s Republic of China that operate in the non-traditional financial industry. Sino was incorporated under the laws of Delaware on March 28, 2014. The units from the initial public offering (including the over-allotment option) were sold at an offering price of $10.00 per unit, generating total gross proceeds of $40,801,000.

SIRION Biotech
SIRION Biotech Private   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

SIRION Biotech is a global leader in developing research & commercial grade viral vector solutions for industry and academic partners who are developing gene therapies and vaccines. With the broadest vector portfolio that produces products with the highest yield, purity and quality, SIRION provides reliable, custom-engineered viral vector solutions for leading pharmaceutical companies, development-stage biotechnology companies and academic scientists and researchers. SIRION Biotech strives to be the world’s leading viral vector partner, meeting a critical need in the process of bringing groundbreaking gene therapies and novel vaccines to patients across a broad spectrum of indications.

SITO Mobile
SITO Mobile (SITO)   Presenting on Day 2
Industry Sector: Technology - Media & Internet

SITO Mobile Ltd., formerly Single Touch Systems, Inc. is a mobile engagement platform serving businesses, advertisers and brands for the purpose of building brand awareness, loyalty and sales. Through its patented technologies and an easy-to-use platform, the Company provides solutions that combine location-based advertising, SMS capabilities, and voice, to allow brands to communicate seamlessly across all mobile devices in key locations. In July 2014, SITO Mobile acquired DoubleVision Networks, a privately held mobile audience buying and targeting platform. Post the DoubleVision integration, SITO Mobile will now leverage real-time bidding algorithms that dynamically assess the open mobile advertising inventory for its "Followme" product, to deliver a superior ROI for its clients. SITO Mobile has built a strong IP portfolio around reservation-based and ad-supported streaming of digital media. The Company became cash flow positive in the first quarter of FY 2014. SITO Mobile has a new CEO, new lead Director, and a new culture. The Company recently secured $10 million in senior secured debt and $1 million in equity investment for general working capital purposes.

SMTP, Inc (SMTP)   Presenting on Day 2
Industry Sector: Technology - Media and Telecommunications

SMTP is a provider of services to facilitate email delivery, with a focus on marketing email delivery, but also supporting bulk and transactional sending, reputation management, compliance auditing, abuse processing and issue resolution. Our services provide customers with the ability to increase the deliverability of email with less time, cost and complexity than handling it themselves. SMTP, Inc. is a dividend-paying, publicly-traded company headquartered in Nashua, NH.

Social Reality Inc.
Social Reality Inc. (SCRI)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Social Reality is a fast growing Internet advertising and platform technology company that provides tools to automate the digital advertising market. The company has grown 560% in the 4th quarter of 2014 and 626% in the first quarter of 2015. SCRIspecializes in both the Real Time Bidding (RTB) and the Social segments of the digital advertising market.

Through their SRAX™ platform,SCRIbuilds trading desks for brands and ad agencies that allow them to buy Display, Mobile, Video and Native advertising across a number of RTB exchanges. Social Reality provides these services on a self service and on a managed service basis. They also provide tools that allow publishers to tap into many of the largest RTB exchanges and generate the highest yield for their inventory.SCRIoperates on both the buy-side and sell-side of the RTB exchange market.

On the Social side of the business, through their GroupAd platform,SCRIprovides tools that allow for brands and agencies to identify who their influencers are and provide them tools to turn them into brand advocates. Once the brands identify their key influencers, the system allows them to create look alike audiances that can be targeted on the RTB platforms.

Solar3D, Inc.
Solar3D, Inc. (SLTD)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Solar3D, Inc. is a leading provider of photovoltaic (PV) /solar power systems and solutions and the developer of a proprietary high efficiency solar cell. Through its subsidiaries, SUNworks and recently acquired, MD Energy, Solar3D focuses on the design, installation and management of solar power systems for commercial, agricultural and residential customers. SUNworks, one of the fastest growing solar systems providers in northern California, has delivered hundreds of commercial systems and has the capability of providing systems as large as 25 megawatts. MD Energy focuses its operations on the commercial market for Southern California. Solar3D is also developing a patent-pending 3-dimensional solar cell to maximize the conversion of sunlight into electricity. The Company's mission is to further the widespread adoption of solar power by deploying affordable, state-of-the-art systems and developing new solar technologies. Solar3D empowers the customer through arranging affordable ownership programs which offer many benefits over leasing by applying all available government incentives and flexible financing options. Solar3D has a successful business model that differentiates itself from its competitors with a system that identifies and implements a profitable consolidation strategy to accelerate acquisitions to build Solar3D into the next solar powerhouse in a fractured industry. On March 4, 2015, Solar3D completed a public offering (underwritten by Cowen and Company) and raised gross proceeds of $12.5 million in connection with a simultaneous uplist to NASDAQ. Solar3D generated revenues of $5.7 million during the quarter ended March 31, 2015, a 440% year-over-year growth rate.

Sports Field Holdings, Inc.
Sports Field Holdings, Inc. (SFHI)   Presenting on Day 2
Industry Sector: Retail and Consumer Products

Sports Field Holdings, Inc., through its wholly owned subsidiary Sports Field Engineering, Inc., is a product development, engineering and design-build construction company, engaged in the design, engineering, constructing, and construction management of athletic facilities, and sports complexes. Construction management of sports facilities and synthetic turf sales are the two primary lines of business. These lines of business can be categorized as design, development, and manufacturing of sports surfacing products and associated pre-engineered construction systems.

Staffing 360 Solutions, Inc
Staffing 360 Solutions, Inc (STAF)   Presenting on Day 2
Industry Sector: Software and Business Services

Staffing 360 Solutions, Inc. is a high-growth public company engaged in the execution of a global buy-and-build strategy in the staffing industry, having completed five acquisitions with operations in the US and Europe in the past 24 months. The staffing industry generates a sizable $416 billion per year worldwide and is highly fragmented, with over 15,000 staffing companies that have under $20 million in revenues in the United States alone. The Company believes the staffing industry offers opportunities for accretive acquisitions that will drive its annual revenues to $300 million. The company has already increased revenues from less than $1 million in fiscal 2013 to over $130 million on a current annualized basis. As part of its targeted consolidation model, the Company is pursuing acquisition targets in the finance and accounting, administrative, engineering and IT industries. The Company boasts a management team with decades of industry and M&A experience, and currently has a pipeline of acquisition candidates representing aggregate revenues in excess of $500 million, although there are no assurances that the acquisition of any of these target companies will be consummated. The Company’s management team believes Staffing 360 Solutions is positioned to capitalize on the extraordinary demand for staffing services around the globe, with an unequivocal commitment to building long-term shareholder value.

Stellar Biotechnologies, Inc
Stellar Biotechnologies, Inc (SBOTF)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Stellar Biotechnologies, Inc. is a commercialization stage company focused in the immunotherapy arena, with world-leading technology in Keyhole Limpet Hemocyanin (KLH) protein. KLH is an important immune-stimulating molecule widely used as a key active ingredient in many new immunotherapies, and as an injectable product to assess immune response. We are committed to applying our Stellar KLH™ platform to power the growing field of disease-targeting immune therapies.

Stem Cells Inc.
Stem Cells Inc. (STEM)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

StemCells, Inc. is engaged in the research and development of therapeutics using the Company's proprietary human neural stem cells for treating disorders of the central nervous system. The Company has recently completed enrollment in two Phase I/II clinical trials. One in dry age related macular degeneration and one in spinal cord injury. The Company has reported positive interim results in both of these studies and final top-line results will be available in the middle of 2015. The Company recently initiated a Phase II controlled proof of concept study in cervical spinal cord injuries with the goal of demonstrating improved motor function in the upper extremities including the hands, arms, wrists and shoulders. Interim results from the first open label cohort in the Phase II spinal cord injury study is expected late 2015. In addition, the company plans to initiate a Phase II controlled study in dry age related macular degeneration this quarter.

Stevia First Corporation
Stevia First Corporation (STVF)   Presenting on Day 2
Industry Sector: Industrials

Stevia First Corp. is an agricultural biotechnology (ag-tech) company that has developed advanced methods for the production of stevia using fermentation for the improvement of traditional stevia farming and processing methods that increase high-purity Reb A stevia output by 2X to 3X per metric ton of leaf or acre planted. Stevia First is focused on the industrial scale production of stevia, the all-natural zero-calorie sweetener that is rapidly transforming the food and beverage industry with a strong intellectual property portfolio related to fermentation-based stevia production methods. The Company is also applying breakthrough technologies in software and the life sciences to develop product applications beyond stevia in the food and nutrition industries that help combat diabetes and obesity. Stevia First has a strong supply chain with experience controlling stevia quality and price from "soil-to-sale" and the Company is ultimately in the business of cultivating health.

Sutor Technology Group Limited
Sutor Technology Group Limited (SUTR)   Presenting on Day 2
Industry Sector: Industrials

Sutor is one of the leading China-based manufacturers and distributors of high-end fine finished steel products used by a variety of downstream applications. The Company utilizes a variety of in-house developed processes and technologies to convert steel manufactured by third parties into fine finished steel products, including hot-dip galvanized steel, pre-painted galvanized steel, acid-pickled steel, cold-rolled steel and welded steel pipe products.

Sysorex Global Holdings Corp.
Sysorex Global Holdings Corp. (SYRX)
Industry Sector: Technology - Media and Telecommunications

Sysorex Global Holdings Corp. is a leading provider of Information Technology Support Services for enterprise level IT environments including full life cycle software development, interface, integration, operational support, and IT Network Infrastructure Modernization Services. With over 30 years of operating history, they provide a wide range of consulting, systems engineering, cyber security, data analytics and program management expertise.

Tapimmune Inc.
Tapimmune Inc. (TPIV)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

TapImmune Inc. is a clinical stage immunotherapy company specializing in the development of innovative technologies for the treatment of cancer, including metastases, and infectious disease. The Company’s peptide or nucleic acid-based immunotherapeutics, comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate a patient’s killer T–cells, helper T–cells and to restore or further augment antigen presentation using proprietary nucleic acid-based expression systems.

TapImmune has completed Phase I studies at the Mayo Clinic in HER2/neu breast cancer and in ovarian and triple-negative breast cancer with a large majority of patients showing T–cell immune responses against the vaccine antigens. Phase II studies on a Folate Receptor Alpha peptide vaccine for the treatment of triple-negative breast cancer are scheduled to start later in 2015.

The Company’s technologies may be used as stand-alone medications or in combination with current treatments.

Theralase Technologies Inc.
Theralase Technologies Inc. (TLT)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Theralase Technologies Inc. (“Theralase®”) in its Therapeutic Laser Technology (“TLT”) Division designs, manufactures and markets patented super-pulsed laser technology indicated for the: elimination of pain, reduction of inflammation and dramatic acceleration of tissue healing for numerous nerve, muscle and joint conditions. Theralase’s Photo Dynamic Therapy (“PDT”) Division researches and develops specially designed molecules called Photo Dynamic Compounds (“PDCs”), which are able to localize to cancer cells and then when laser light activated, effectively destroy them.

Towerstream Corporation
Towerstream Corporation (TWER)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Towerstream Corporation is a leading Fixed Wireless Fiber Alternative company delivering high-speed Internet access to businesses. The Company offers its broadband services in 12 urban markets including New York City, Boston, Los Angeles, Chicago, Philadelphia, the San Francisco Bay area, Miami, Seattle, Dallas-Fort Worth, Houston, Las Vegas-Reno, and the greater Providence area, where the Company is based. In 2013, Towerstream Corporation, formed HetNets Tower Corporation (“HetNets”), a wholly owned subsidiary, to offer a neutral host network solution enabling wireless carriers, cable and Internet companies to expand their network footprint, increase coverage and capacity to their platforms.

True Drinks Holdings, Inc.
True Drinks Holdings, Inc. (TRUU)   Presenting on Day 1
Industry Sector: Retail and Consumer Products

True Drinks is first-to-market with a healthy hydration alternative to the current high-sugar, high-caloric beverages on the market today with AquaBall Naturally Flavored Water. AquaBall is the fastest growing drink in the children’s beverage market and is the only zero calorie, sugar-free product on the market. AquaBall is made with all natural flavors, is sweetened with the natural sweetener Stevia, and is enhanced with B and C Vitamins. AquaBall is packaged in unique spherical bottles which are adorned with Disney and Marvel characters known throughout the world. AquaBall is currently authorized in over 30,000 retail outlets in the United States and is also licensed for sale in China, Canada, Australia and New Zealand.

U.S. Geothermal Inc.
U.S. Geothermal Inc. (HTM)   Presenting on Day 1
Industry Sector: Energy and Natural Resources

U.S. Geothermal Inc., is a leading and profitable renewable energy company focused on the development, production and sale of electricity from geothermal energy. The Company is currently operating geothermal power projects at Neal Hot Springs, Oregon, San Emidio, Nevada and Raft River, Idaho for a total power generation capacity of approximately 45 megawatts. The Company has advanced stage development projects at the Geysers, in California, and a second phase project at San Emidio, Nevada and El Ceibillo, located near Guatemala City, Guatemala. Exploration projects include Crescent Valley, Nevada, and Vale, Oregon. U.S. Geothermal’s growth strategy is to reach 200MW’s of production by 2020, through a combination of internal development and strategic acquisitions.

Vault Nano Inc.
Vault Nano Inc. (Private)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

Vault Nano Inc. is to transform the cancer immunotherapy and vaccine space with its unique vault technology. Using an indigenous human protein forming a natural capsule to be used as delivery of small molecules, cytokines and drugs. Today’s most promising cancer immunotherapy candidates are complex in nature and use adaptive immune cells to combat cancers. We target the cancer by changing the paradigm from ex-vivo cell preparation to an in-vivo therapy by mimicking a lymph node signal to recruit the necessary immune cells directly into the cancer for a systemic anti-cancer response. Our ImmunOncology™ therapy attracts tumor infiltrating lymphocytes (TILs) to combat solid tumors, metastasized cancers, and it is ideal in combination with the new checkpoint inhibitors lacking immune system signalling. Cancer Immunotherapy is the beginning of the end for cancer with a potential total annual market size of $35 billion.

Viatar CTC Solutions Inc.
Viatar CTC Solutions Inc. (VRTT)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

Viatar CTC Solutions is a medical technology company focused on the treatment of patients with metastatic cancer. The company’s lead product, the Viatar™ Therapeutic Oncopheresis System, removes circulating tumor cells from whole blood using label-free cross-flow filtration. Pending regulatory approval targeted for 2016, it will be used as a periodic therapy to improve overall survival for a wide range of solid tumor types such as lung, breast, colon, prostate and gastric cancers. This technology also powers the company’s liquid biopsy products as collection systems for use by researchers and medical oncologists, by providing a greater quantity and purity of circulating tumor cells for genetic analysis and personalized medicine.

Viggle Media, Inc.
Viggle Media, Inc. (VGGL)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Viggle Inc. is a leading entertainment marketing and rewards platform that provides reward points to consumers for watching television and listening to music. Viggle members can redeem their points for a variety of rewards, including music downloads, gift cards, electronics and more. Viggle attracts consumers to specific content such as TV shows or music, drives far above average engagement rates, and captures engagement data behind a verified check-in. Viggle is able to track user actions across multiple entertainment verticals and across online, app and social channels to deliver highly targeted advertising. While members watch TV and listen to music, Viggle delivers mobile advertising far-above-average CTR and engagement rates, and can provide rich campaign data back to network and brand partners.

Viggle's platform, which has over 8 million registered users, consists of the Viggle app, which offers rewards for watching TV, listening to music, or watching web videos; NextGuide, a personalized TV programming guide that helps users sort through endless choices and set reminders when shows air either on TV or on the web; Wetpaint, an entertainment news and social publishing platform reaching an audience of 14M-18M users per month; and the Viggle Store, a rewards destination where visitors can redeem Viggle Points for digital downloads.

VirtualScopics, Inc.
VirtualScopics, Inc. (VSCP)   Presenting on Day 1
Industry Sector: Healthcare and Life Sciences

VirtualScopics, Inc. is a leading provider of clinical trial imaging solutions to accelerate drug and medical device development. For risk-averse, time-constrained Clinical Trial Study Teams, Medical Directors and Imaging Scientists who require quality imaging data delivered on-time, within budget and on a consistent basis, VirtualScopics’ clinical trial imaging solutions are an inspired true exception to commonly-accepted services provided by other clinical trial imaging providers. Because of the scientific and operational flexibility and responsiveness they can offer, VirtualScopics’ clinical trial imaging solutions deliver special performance advantages compared to other image service providers that offer common, everyday clinical trial imaging services.

Viscount Systems, Inc.
Viscount Systems, Inc. (VSYS)   Presenting on Day 1
Industry Sector: Technology - Media and Internet

Viscount is the leading provider of next generation, IT-centric access control and identity management applications. Viscount’s Freedom application platform allows seamless unification of the physical and digital security worlds by replacing discrete, self-contained systems with an integrated security system that is sophisticated enough to protect today’s critical business assets, and flexible enough to keep up with the evolving IT infrastructures of government and private organizations.

VolitionRx Limited
VolitionRx Limited (VNRX)   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream – an indication that cancer is present.

VolitionRx’s goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx’s research and development activities are currently centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the US and ultimately, worldwide.

Vuzix Corporation
Vuzix Corporation (VUZI)   Presenting on Day 2
Industry Sector: Retail and Consumer Products

Vuzix is a leading developer and supplier of smart glasses and video eyewear products in the consumer, enterprise and industrial markets. The Company’s products - personal display and wearable computing devices offer users a portable high quality viewing experience that provide solutions for mobility, wearable computing displays and Virtual and Augmented Reality (AR). The Company’s products have won 20 Consumer Electronics Show Innovations awards (including 4 for CES 2015), with select products being the world’s best-innovation in their category. With its origins in defense R&D for next-generation military display solutions, Vuzix became one of the leading personal display suppliers to the U.S. military. In 2012, Vuzix sold its military products division and is now focused on pursuing the consumer and enterprise markets for wearable computing and personal display devices, an industry projected by IMS Research to generate revenues of $6 Billion by 2016. The Company holds 41 patents and 10 additional patents pending.

xG Technology Inc.
xG Technology Inc. (XGTI)   Presenting on Day 2
Industry Sector: Technology - Media and Internet

Founded in 2002, xG Technology has created a broad portfolio of intellectual property that makes wireless networks more intelligent, accessible, affordable and reliable. The company is the developer of xMax, a patented all-IP cognitive radio network system that enables secure, robust mobile broadband communications for private, consumer and government networks. xMax can solve the crisis facing the wireless industry caused by data-hungry devices and applications that are straining network capacity. It eliminates the need to acquire scarce and expensive licensed spectrum, thus lowering the total cost of ownership for wireless broadband access.

The xMax system delivers always-available voice, video and data services to both fixed and mobile users, and is interoperable with existing cellular and dedicated networks without being dependent on them. xMax incorporates advanced optimizing technologies that include spectrum sharing, interference mitigation, multiple-input multiple-output (MIMO) and software defined radio (SDR). These and other technologies make xMax ideal for wide area, as well as rapid emergency communication deployment in unpredictable environments and during fluid situations. xG offers solutions for numerous industries worldwide, including emergency response and public safety, military, urban and rural wireless broadband, utilities, and critical infrastructure.

XRpro Sciences, Inc.
XRpro Sciences, Inc. Private   Presenting on Day 2
Industry Sector: Healthcare and Life Sciences

XRpro Sciences, Inc. provides a unique platform for drug discovery and development services featuring high throughput ion channel assays for the pharmaceutical industry. The Company’s proprietary advances in X-ray fluorescence provide measurements that would otherwise be difficult or impossible applying other readily available technologies. XRpro® technology directly measures the activity of a drug target, without the need for costly and artifact-causing chemical dyes or radiolabels.

High throughput XRpro® technology allows the performance of assays that were previously unavailable or unacceptably expensive when performed using other technologies. Significant advantages of XRpro® according to customers include the ability to perform measurements in challenging matrices, such as serum (blood), and the ability to conduct assays of non-electrogenic transporters.

* Important note about presenting companies

The information contained on this website should not be construed as an endorsement of any entity included herein, is not intended to be used, and cannot be used, for the purpose of promoting, marketing, or recommending to another party any transaction or matter. Neither the information nor the Marcum MicroCap Conference shall constitute an offer or the solicitation of an offer to sell or buy any security. Information about the presenting companies, and information contained on presenting company websites has been prepared by and is the responsibility of each of the individual presenting companies. Marcum has not reviewed such information and does not provide any assurance that such information is accurate or complete.